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Abstract 
In eukaryotic cells, membrane-bound vesicles carry cargo between intracellular 
compartments, to and from the cell surface, and to the extracellular environment. Many 
conserved families of proteins are required for properly localized vesicle fusion, 
including the multi-subunit tethering complexes and the SNARE complexes. These 
protein complexes work together to promote proper vesicle fusion in other trafficking 
pathways. Contrary to these other pathways, our lab previously suggested that the exocyst 
subunit Sec6, a component of the exocytosis-specific tethering complex, inhibited 
Sec9:Sso1 SNARE complex assembly due to interactions in vitro with the SNARE 
protein Sec9 (Sivaram et al., 2005).  
My goal for this project was to test the hypothesis that Sec6 inhibited SNARE 
complex assembly in vivo. I therefore chose to generate Sec6:Sec9 loss-of-binding 
mutants, and study their effect both in vitro and in vivo. I identified a patch of residues on 
Sec9 that, when mutated, are sufficient to disrupt the novel Sec6-SNARE interaction. 
Additionally, I found that the previous inhibitory role for Sec6 in SNARE assembly was 
due to a data mis-interpretation; my re-interpretation of the data shows that Sec6 has a 
mild, if any, inhibitory effect on SNARE assembly. My results suggest a potential 
positive role for Sec6 in SNARE complex assembly, similar to the role observed for other 
tether-SNARE interactions. 
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CHAPTER I: INTRODUCTION 
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Intracellular Trafficking 
 Intracellular trafficking, the movement of membrane-bound or soluble cargo 
between distinct cellular compartments, is an essential and highly conserved process in 
all eukaryotic cells. It requires a vesicle budding off a donor organelle, being transported 
to its site of fusion, and subsequently fusing with the target membrane (Herrmann and 
Spang, 2015). These pathways are required for the overall health and function of the cell 
and the organism; defects in various trafficking pathways can result in kidney disease, 
defective neuronal outgrowth, and various lysosomal storage disorders (Horton et al., 
2005; Platt et al., 2012; Schaeffer et al., 2014). 
One of the best studied organisms for all stages of intracellular trafficking is the 
budding yeast Saccharomyces cerevisiae. The high level of conservation of these 
pathways, coupled with the genetic 
tractability of yeast as a model organism, 
suggests that these processes can be 
dissected in yeast with the findings being 
transferred to higher eukaryotes (Feyder et 
al., 2015). In yeast, intracellular trafficking 
encompasses several distinct trafficking 
steps (Figure 1.1). The first, endoplasmic 
reticulum (ER) to Golgi complex 
trafficking, is required for the initial 
movement of secreted or membrane 
Figure 1.1 – A schematic representation of the various 
intracellular trafficking stages in the budding yeast 
Saccharomyces cerevisiae. MVB – multi vesicular body, 
ER – endoplasmic reticulum. 
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proteins from their folding in the ER to their maturation in the Golgi. Once these proteins 
arrive at the Golgi, they can follow one of two pathways – ER resident proteins are 
returned via an ER retrograde pathway, and proteins moving on through the secretory 
pathway are matured in the Golgi via an intra-Golgi pathway. After Golgi maturation is 
complete, the proteins are sorted; plasma membrane and secreted proteins are brought to 
the cell surface by the exocytic trafficking pathway, while vacuolar proteins passing 
through the endosome are trafficked by the Golgi-endosome trafficking pathway. Arrival 
at the endosome can also occur during endocytic recycling – this is required for retrieval 
of plasma membrane proteins, which can then be brought back to the Golgi for another 
round of secretion after ligand removal or degraded through trafficking to the vacuole. 
The end-stage of trafficking is from the endosome, through the multi vesicular body, and 
to the vacuole for protein degradation by the homotypic vacuolar fusion pathway (Feyder 
et al., 2015).  
Each of these distinct trafficking pathways are tightly regulated, as mis-sorting of 
cargo or mis-localization of fusion events can lead to severe cellular defects (Olkkonen 
and Ikonen, 2006). Additionally, each intracellular route is mediated by members of 
conserved protein families including (but not limited to) small GTPase proteins on both 
membranes, specific interactions with lipids, the Soluble N-ethylmaleimide Attachment 
protein Receptor (SNARE) complexes, the Sec1/Munc18 family of SNARE regulatory 
proteins, and tethering complexes (discussed in detail below). These protein families 
work together, by mechanisms not yet fully characterized, to ensure the overall health of 
the cell/organism. 
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 Once the cargo-containing vesicle arrives at the proper membrane, the process of 
vesicle fusion occurs in a stepwise manner (Figure 1.2). The fidelity of this process is as 
important as cargo sorting and vesicle trafficking, and defects in these final stages of 
trafficking cause additional severe cellular defects (Olkkonen and Ikonen, 2006). The 
tethering factor localized at the fusion site is thought to form the initial contact between 
the vesicle and the target membrane through interactions with Rab and Rho/Ral GTPases 
on one or both membranes. These prenylated small proteins interact with either GTP or 
GDP; GTP-bound GTPases are associated with the membrane, and therefore function as 
a “switch” for membrane recruitment of downstream effectors. Activation of the GTPase, 
and subsequent cleavage of GTP into GDP, results in the removal of the GTPase from the 
membrane (Segev, 2011). In order to facilitate another round of membrane binding, 
guanine nucleotide exchange factors (GEFs) exchange the non-functional GDP for a new 
GTP molecule; this process can be inhibited by GDP dissociation inhibitors (GDIs). This 
initial interaction bridges the distance between the vesicle and the target membrane and 
allows the SNARE proteins to engage, which is sufficient to drive membrane fusion and 
Figure 1.2 - Steps of vesicle fusion, depicted for exocytic trafficking. A vesicle arrives at its site of fusion, and first 
contacts the tethering complexes. The SNARE proteins then engage, which is sufficient to drive membrane fusion. 
During this process, the SM proteins interact with both the tethering complex and the SNARE proteins/SNARE 
complex in a variety of ways depending on the trafficking step. The interactions that occur between each of these 
protein families during this process are specific to each trafficking step, and contribute to the overall regulation of the 
spatial and temporal delivery of vesicles. 
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release the contents of the vesicle (Jahn and Scheller, 2006). Prior to SNARE assembly, 
the SM protein family functions to regulate SNARE assembly through a generally 
uncharacterized mechanism (Südhof and Rothman, 2009). Each trafficking step requires 
specific members of these conserved protein families, and conserved interactions 
between these families (described in detail below) contribute to the overall regulation of 
vesicle fusion (Bonifacino and Glick, 2004).  
  
 6 
SNARE Complexes 
The SNARE complex is a stable four-helix bundle that is the core of the 
membrane fusion apparatus (Jahn and Scheller, 2006). Formation of this stable complex 
is sufficient to overcome the energy barrier to membrane fusion, and has been shown to 
be sufficient for membrane fusion in simplified in vitro systems (van den Bogaart et al., 
2010; Weber et al., 1998). These proteins are conserved through higher eukaryotes and 
required for all stages of membrane trafficking through the secretory pathway in all 
organisms. Mutations in individual SNARE proteins, changes in SNARE protein 
expression levels, and changes in SNARE complex assembly all result in various cellular 
and organismal defects from yeast through humans (Garcia-Reitböck et al., 2010; 
Johnson et al., 2008; Kama et al., 2011). 
The various SNARE proteins from each trafficking step are identified by their 
“SNARE motif”, a characteristic coiled-coil heptad repeat of hydrophobic residues 
generally followed by a transmembrane domain (Rossetto et al., 1994). Many SNARE 
proteins also contain N-terminal domains that provide additional functions; these 
domains can slow or inhibit formation of the SNARE complex, bind critical interaction 
partners, or perform other not-yet-characterized actions (Jahn and Scheller, 2006).. 
For the majority of trafficking steps, SNARE assembly proceeds in two stages as 
shown in Figure 1.2. First, the SNAREs localized on the target membrane (t-SNAREs) 
assemble into an “acceptor” complex. Then, the vesicle-bound SNARE proteins (v-
SNAREs) “zip” into the acceptor complex from N-terminus to C-terminus (Fasshauer, 
2003). Each of the helices provide one ionic residue at the center of the assembled four-
 7 
helix bundle: three glutamine residues from the t-SNAREs, and one arginine residue from 
the v-SNARE (Sutton et al., 1998). These charged residues at the center of an otherwise 
hydrophobic complex core are required for complex stability; loss of the glutamine 
residues, or rotation of the charges, results in destabilized or non-fusogenic complexes 
(Katz and Brennwald, 2000; Ossig et al., 2000; Scales et al., 2000). The assembled 
SNARE complex requires the ATPase activity of the Sec17 and Sec18 complex (α-SNAP 
and NSF in mammalian systems, respectively) for disassembly (Hayashi et al., 1994; 
Söllner et al., 1993a). Due to the energetic favorability of assembling the SNARE 
complex and the stability of the assembled complex, regulation of vesicle fusion 
necessitates the regulation of SNARE complex assembly.  
In exocytosis, the yeast t-SNAREs Sso1/2 (syntaxin family in mammals) and 
Sec9 (SNAP-25 family in mammals) form a binary acceptor complex that binds the v-
SNAREs Snc1/2 
(VAMP/synaptobrevin 
family in mammals) to 
drive membrane fusion 
(Aalto et al., 1993; 
Brennwald et al., 1994; 
Gerst et al., 1992; Söllner et 
al., 1993b; Weber et al., 
1998) (Figure 1.3). Prior to 
Figure 1.3 - The assembled exocytic SNARE complex in yeast. The t-
SNAREs Sec9 (green) and Sso1 (pink) form an acceptor complex that the v-
SNARE Snc2  (blue) zippers into upon vesicle arrival. This requires removing 
the autoinhibition of the Sso1 N-terminal Habc domain prior to t-SNARE 
complex formation. PDB code 3B5N, PyMol v. 1.7.4 
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complex formation, both Sec9 and Snc2 
are intrinsically disordered proteins (IDPs) 
and fold into their helical SNARE 
conformations during assembly of the 
SNARE complex (Fasshauer et al., 1997; 
Nicholson et al., 1998; Rice et al., 1997).  
When the SNARE proteins were 
first identified, it was hypothesized that 
SNARE pairing was sufficient to encode 
the specificity required for membrane 
fusion (Söllner et al., 1993b). However, 
several lines of evidence indicate SNAREs are not the sole specificity determinants and 
that specific control of SNARE complex assembly is required to prevent the formation of 
premature, mislocalized, or non-specific SNARE complexes that may result in the 
incorrect delivery of important cargo. First, yeast SNAREs can form fusion-competent 
complexes promiscuously in vitro (McNew et al., 2000). Vesicles containing the exocytic 
Sso1:Sec9 t-SNARE complex can fuse with vesicles containing v-SNAREs other than 
Snc1/2, and vesicles loaded with the vacuolar t-SNARE complex (containing Vam3, 
Vti1, and Vam7) can fuse with vesicles containing non-vacuolar v-SNAREs including the 
exocytic/endocytic Snc2 (Izawa et al., 2012). This promiscuity extends to mammalian 
cells – SNAREs from various intracellular compartments can form stable non-cognate 
SNARE complexes in vitro (Fasshauer et al., 1999; Hohenstein and Roche, 2001; Yang et 
Figure 1.4 - Intracellular localization of the exocytic t-
SNAREs in budding yeast. Sso1 (pink) and Sec9 (green) 
are broadly distributed along the plasma membrane, and 
therefore not properly localized to sites of secretion. 
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al., 1999). Secondly, at least in exocytosis, protein localization is not sufficient to 
promote specific SNARE pairing. The exocytic t-SNAREs Sec9 and Sso1 are not 
restricted to the yeast bud tips and mother-daughter necks, where secretion is occurring, 
but rather are distributed along the plasma membrane (Brennwald et al., 1994) (Figure 
1.4). One example of regulation comes from Sso1; like many syntaxins, Sso1 contains an 
autoinhibitory domain that can prevent premature binary Sso1:Sec9 complex assembly 
(Dietrich et al., 2003; Weimbs et al., 1997). However, this autoinhibition is not absolute 
because SNARE complex assembly can proceed in vitro, without the addition of putative 
“opening” factors, albeit at non-physiological rates (Munson et al., 2000; Nicholson et 
al., 1998). Similarly, the mammalian exocytic SNAREs can form non-fusogenic SNARE 
complexes at the Golgi if not inhibited prior to trafficking to the cell surface (Medine et 
al., 2007). Therefore, other levels of activation and/or inhibition are necessary to prevent 
inappropriate complex formation and subsequent vesicle fusion. These are likely 
provided by the protein families that are properly localized at sites of secretion, such as 
the SM proteins and the tethering factors.  
 10 
SNARE Regulatory Proteins 
Sec1/Munc18 (SM) Proteins 
The Sec1/Munc18 (SM) protein family members function as SNARE regulators. 
These proteins interact with SNARE proteins or SNARE complexes in 4 distinct modes – 
through interactions with the autoinhibited conformation of syntaxin, an N-terminal 
peptide found on the N-terminal regulatory domain of syntaxin, the fully assembled 
SNARE complex, and the SNARE domain of the v-SNARE (Baker et al., 2015; Carr and 
Rizo, 2010; Furgason et al., 2009; Toonen and Verhage, 2007) and references therein). 
However, despite years of careful study, the exact mechanism of action for the SM 
proteins remains elusive; it is not clear whether they primarily function to stabilize 
individual SNARE proteins, promote the formation of cognate SNARE complexes, 
stabilize properly assembled complexes, help stimulate membrane fusion after SNARE 
assembly, prevent formation of non-cognate SNARE complexes, or some combination of 
all of these roles.  
The SM proteins were identified in both the worm Caenorhabditis elegans and in 
the earliest secretory screen in yeast; however, it wasn’t until later that these proteins 
were found to be part of a related family required for synaptic transmission and various 
intracellular trafficking pathways (Aalto et al., 1992; Hosono et al., 1992; Novick et al., 
1980). Once the yeast exocytic homologue Sec1 was cloned and studied in vitro, it was 
found to bind fully assembled exocytic SNARE complexes and increase the rate of fusion 
of liposomes reconstituted with exocytic SNARE proteins (Carr et al., 1999; Scott et al., 
2004). However, mechanistic insight into how Sec1 promotes this increased fusion rate 
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has been difficult to obtain. Therefore, genetic and biochemical binding information has 
provided the bulk of the mechanistic analysis to date.  
There are lines of evidence of specific protein-protein and genetic interactions for 
each SM family member; however, they have not yet revealed a common mechanism of 
action, or a thorough understanding of how the family promotes SNARE assembly. 
Mutational analysis of the exocytic SM protein Sec1 suggests that it functions both 
before and after SNARE complex assembly. One class of mutations affects the ability of 
SNARE complexes to assemble prior to vesicle fusion, while a second class affects 
binding to the assembled SNARE complex. Both classes cause growth and secretion 
defects (Hashizume et al., 2009). The neuronal Sec1 homologue, Munc18, binds the 
autoinhibited conformation of its syntaxin and stabilizes that conformation; it then binds 
to partially assembled SNARE complexes to mediate vesicle priming prior to fusion, a 
neuronal-specific adaptation for fast vesicle release (Deák et al., 2009). Vps45, the SM 
protein involved in pre-vacuolar/endosomal trafficking, directly regulates the protein 
levels of its cognate syntaxin Tlg2. Deletion of Vps45 results in reduced protein levels of 
Tlg2, which in turn results in decreased levels of assembled SNARE complexes (Bryant 
and James, 2001). Additionally, it promotes formation of SNARE complexes by relieving 
the inhibition of the N-terminal autoinhibitory domain of the mammalian Tlg2 
homologue (Struthers et al., 2009). Sly1 and Vps33 (the yeast SM proteins required for 
Golgi and endo-vacuolar fusion, respectively) work together with the Sec17/Sec18 
disassembly machinery to protect cognate SNARE complexes from disassembly prior to 
fusion, resulting in an increased level of assembled SNAREs (Lobingier et al., 2014). 
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Vps33 has also been shown to interact with both the t-SNARE Vam3 and the v-SNARE 
Nyv1 (Lobingier and Merz, 2012; Sato et al., 2000). However, the most compelling 
mechanistic evidence of SM protein function was published earlier this year, based on a 
pair of crystal structures – if Nyv1 and Vam3 interact with Vps33 simultaneously, the 
SNARE proteins would be correctly aligned for initial zippering of the SNARE complex 
up to the ionic layer (Baker et al., 2015). Most of the SM proteins also interact with their 
cognate tethering complexes, either as a transient interaction or as a stoichiometric 
component of the intact complex (discussed more below). Therefore, the SM proteins are 
crucial positive regulators of SNARE assembly, although it remains to be determined 
whether they function by the same mechanism.  
 
Lethal giant larvae (Lgl) proteins Sro7 and Sro77 
 The lethal giant larvae (Lgl) family are another class of SNARE regulatory 
proteins that were originally identified as tumor suppressors in Drosophila melanogaster, 
and later in mammalian cells where they contributed to establishing cell polarity (Gateff, 
1978; Manfruelli et al., 1996). Members of this family have been shown to interact with 
both the assembled SNARE complex and the t-SNARE Sec9 in yeast (Lehmberg et al., 
1999). In mammalian cells, they interact with the t-SNARE syntaxin and the partially 
assembled “acceptor” SNARE complex (Fujita et al., 1998). While the overall mode of 
these interactions are different, they serve a similar function – slow down or prevent 
SNARE complex assembly, either by sequestering one of the t-SNARE components or 
competing with the v-SNARE for binding (Ashery et al., 2009; Hattendorf et al., 2007). 
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However, as the deletion of these proteins in yeast is not lethal, it is unclear if this is an 
essential function in polarized exocytosis (Lehmberg et al., 1999). 
 The Sro7/77 proteins in yeast physically interact with other members of the late 
secretory pathway including the vesicle-associated GTPase Sec4, the class V myosin 
motor Myo2, and the exocyst tethering complex component Exo84 (Gangar et al., 2005; 
Grosshans et al., 2006; Rossi and Brennwald, 2011; Watson et al., 2015; Zhang et al., 
2005). The interaction with Sec4 has been implicated in vesicle clustering prior to vesicle 
associate with the plasma membrane, suggesting a role in tethering, while the interaction 
with Myo2 has been implicated in recruiting Sro7 to vesicles; however these roles are in 
contrast to the localization of the protein, which is primarily membrane peripheral similar 
to Sso1 (Lehmberg et al., 1999). Additionally, deletion of Sro7/77 results in a change in 
vesicle cargo, suggesting a role in cargo sorting at the Golgi, which also does not agree 
with the primary protein localization (Forsmark et al., 2011; Wadskog et al., 2006). 
Therefore, while the role of Sro7/77 as a SNARE regulator seems relatively established 
in vitro, it is unclear what the primary function of these proteins are in vivo.  
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Tethering Complexes 
The Multisubunit Tethering 
Complexes (MTCs) are proposed to 
promote the initial interaction between a 
vesicle and its target membrane via 
interactions with lipids and small GTPases 
on both membranes. Most stages of 
trafficking are associated with a tethering 
complex (Figure 1.5), and while these 
complexes differ in overall subunit 
composition and number, they each 
interact with the same families of proteins 
– small GTPases, SM proteins, and either SNARE proteins or SNARE complexes. Many 
of these tethering complex also interact with the specific GEF for their GTPases. 
Additionally, these complexes have been shown to generally function upstream of 
SNARE assembly, and therefore upstream of vesicle fusion (Bröcker et al., 2010).  
Despite the differences in subunit number and general complex architecture, a 
subset of tethering complexes has been defined based on the secondary structure of the 
individual subunits - the Complexes Associated with Tethering Containing Helical Rods 
(CATCHR) family (Yu and Hughson, 2010). As the name suggests, these complexes 
contain proteins that are either shown or predicted to be composed of helical bundles, 
suggesting divergent evolution. The remaining complexes have a more diverse subunit 
Figure 1.5 - Overview of each tethering complex in 
budding yeast, and where each complex acts in the 
trafficking pathways 
 15 
composition, and are therefore classified as “non-CATCHR” complexes; however, they 
still share many of the same protein family interactions, suggesting commonalities across 
all of the complexes.  
 
Transport Protein Particle (TRAPP) Complexes 
The TRAPP complexes, of which there are three identified in yeast, are putative 
tethering factors that function in ER to Golgi transport (TRAPPI), intra-Golgi trafficking 
(TRAPPII), and autophagosome formation (TRAPPIII) (Barrowman et al., 2010), and 
references therein). The best evidence of tethering for this complex is that ER-derived 
vesicles do not associate or fuse with Golgi membranes in vitro in the absence of whole 
cell lysate containing the TRAPPI subunit Bet3 (Barrowman et al., 2000). However, as 
this whole cell lysate may have provided additional required factors, this is not 
conclusive evidence of tethering by the complex.  
The TRAPP complexes share the least similarity with the other tethering 
complexes based on their interacting partners. They have been shown to interact with 
coat proteins and have specific subunits that differentiate ER-derived COPII coated 
vesicles from the Golgi-derived COPI coated vesicles (Sacher et al., 2001). Additionally, 
TRAPPI and TRAPPII can function as a GEF for Ypt1, a small Rab GTPase found on 
ER-derived vesicles and required for fusion with the Golgi (Wang et al., 2000). However, 
no interaction has been demonstrated between TRAPP and either an SM protein or 
SNARE proteins/complexes. Therefore, the role of TRAPP complexes as an MTC is the 
least evident based on its interacting partners.  
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Homotypic Fusion and Vacuolar Protein Sorting (HOPS) Complex and Class C 
Core Vacuolar/Endosomal Tethering (CORVET) Complex 
The HOPS and CORVET complexes are required for early endosomal homotypic 
fusion, early to late endosomal fusion, and vacuolar/lysosomal fusion. As these 
subcellular compartments can be purified, as well as the tethering complexes associated 
with them, these are some of the few trafficking steps that have been fully re-constituted 
in vitro and are therefore well-characterized (Balderhaar et al., 2013; Conradt et al., 1992; 
Haas, 1995; Stroupe et al., 2006). They are also the only tethering factors that have been 
shown to be bona fide tethers.  
HOPS and CORVET are unique amongst MTCs because they are composed of a 
shared core of four subunits; each has two additional unique subunits that promote 
binding to specific Rab family GTPases. HOPS interacts with the Rab7 homologue Ypt7, 
and primarily promotes fusion with the Ypt7-positive lysosomal/vacuolar compartment 
(Price et al., 2000; Seals et al., 2000). CORVET interacts with the Rab5 homolog Vps21, 
and primarily promotes early endosomal fusion and fusion between the early and late 
endosomes, both of which are Vps21/Rab5 positive (Peplowska et al., 2007). In addition, 
unlike other tethering factors, HOPS/CORVET incorporate an SM protein (Vps33) into 
the complex rather than recruiting it when needed (Seals et al., 2000). It is through this 
subunit that many of the SNARE interactions occur (discussed more below). Another 
common interaction that HOPS shares with other tethering factors is between the tether 
and the GEF for its Rab GTPase. To this end, one of the HOPS-specific subunits has been 
suggested to function as a GEF for Ypt7 in yeast, and the HOPS complex has been shown 
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to interact with the Ccz1/Mon1 GEF dimer (Nordmann et al., 2010; Wurmser et al., 
2000); however, in mammalian systems no evidence of GEF activity has been shown for 
the HOPS complex (Peralta et al., 2010). These interaction similarities suggest that 
HOPS shares conserved functions with the other tethering complexes. 
 
Dependence on Sly1 (Dsl1) Complex 
The CATCHR family Dsl1 complex is the smallest of all known tethering 
complexes with only three core subunits – Dsl1, Tip20, and Dsl3/Sec39 (Spang, 2012). It 
is localized at the ER and is required for specific recognition of COPI coated Golgi-
derived vesicles prior to fusion with the ER (Andag et al., 2001; Reilly et al., 2001); 
mutations in the Tip20 subunit lead to ER-derived COPII vesicles re-fusing with the ER, 
suggesting that the complex is no longer able to differentiate between COPI and COPII 
coats (Kamena, 2004).  
The Dsl1 complex shares many of the same interactions with other tethering 
factors, but is lacking one notable interaction - interactions with GTPases on either 
membrane have not been shown. However, the Dsl1 subunit interacts with the COPI coat 
of the incoming vesicle, while the Dsl3 and Tip20 subunits interact with SNARE proteins 
on the target membrane (Zink et al., 2009). Therefore, while the switching action of a 
GTPase is likely not used to modulate the interaction with the vesicle, the un-coating of 
the vesicle may provide a similar mechanism for proceeding to SNARE complex 
assembly (Zink et al., 2009). Additionally, it has been postulated that this un-coating is 
required to access the v-SNARE, which would help to prevent SNARE complex 
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assembly prior to specific un-coating of the vesicle (Zink et al., 2009). The complex also 
interacts with the SM protein Sly1 – the same SM protein that functions in retrograde 
Golgi trafficking through interactions with the COG complex (Kraynack et al., 2005). 
Therefore, it participates in a portion of the same interactions that tie together the 
functionality of the various tethering complexes. 
 
Golgi Associated Retrograde Protein (GARP) Complex 
GARP is a late-Golgi-localized MTC with subunits that are primarily helical 
bundles, placing it into the CATCHR family of MTCs (Bonifacino and Hierro, 2011). It 
was first identified as the three subunit Vps52/53/54 complex in yeast, and is required for 
protein sorting at the late Golgi (Conibear and Stevens, 2000); a fourth subunit, Vps51, 
was later identified (Conibear et al., 2003). This complex has also been identified in 
mammalian cells in two forms – GARP containing the Vps54 subunit, and EARP 
containing a novel protein syndetin (Schindler et al., 2015). The EARP complex localizes 
to recycling endosomes rather than the late Golgi, and depletion of the syndetin subunit 
results in delayed recycling back to the cell surface. Therefore, GARP and EARP are 
required for various stages of post-endosomal trafficking based on their localization 
patterns. 
As observed for most MTCs, GARP interacts with the Golgi-localized Ypt6 
GTPase, and several domains of GARP subunits have been identified as important for 
interactions with the incoming vesicle; however, the interacting partner(s) on the 
incoming vesicle have yet to be identified (Siniossoglou, 2005; Siniossoglou and Pelham, 
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2001). Similarly, no physical interaction has yet been identified between any of the 
GARP subunits and an SM protein. However, one group identified a synthetic genetic 
interaction between the Vps53 subunit and Sly1, the SM protein that functions at the 
Golgi, suggesting that Sly1 may also be involved in Golgi retrograde transport 
(VanRheenen et al., 2001). GARP also has not been shown to physically interact with 
any GEFs, but several different studies have identified synthetic genetic interactions in 
high throughput screens between components of GARP and the Ric1/Rgp1 dimeric GEF 
for Ypt6 (Costanzo et al., 2010; Hoppins et al., 2011; Tong, 2004).  
 
Conserved Oligomeric Golgi (COG) Complex 
The COG complex is the MTC necessary for retrograde transport between Golgi 
compartments, and is one of the best studied CATCHR complexes. It is composed of 8 
subunits that form two separate “lobes” connected through the COG1 and COG8 subunits 
(Willett et al., 2013b), and references therein). Unlike other members of the CATCHR 
family, work in cell-free systems suggested that COG can tether vesicles prior to fusion 
(Cottam et al., 2013). Additionally, COG has been shown to be required upstream of 
vesicle fusion: depletion of various COG subunits results in a build-up of vesicles at the 
Golgi (Wuestehube et al., 1996; Zolov and Lupashin, 2005).  
To provide its tethering function, COG has been shown to interact with small 
GTPases on both the vesicle membrane and target membrane. In yeast, these interactions 
are limited to two Golgi-associated Rab-family GTPases (Suvorova et al., 2002; Yu et al., 
2008). Mammalian COG interacts with a more extensive suite of Rab family GTPases, 
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including the Rab family homologues from yeast (Fukuda et al., 2008; Miller et al., 
2013). The COG4 subunit has also been shown to physically interact with the SM protein 
Sly1 (Laufman et al., 2009), and several COG subunits genetically interact with the GEF 
for Ypt6, Ric1 (Costanzo et al., 2011; Hoppins et al., 2011; Schuldiner et al., 2005; Tong, 
2004). Finally, COG has several conserved interactions with its cognate SNARE proteins 
and assembled SNARE complexes (discussed more below).  
 
The Exocyst Complex 
The exocyst complex is the MTC proposed to recognize and tether secretory 
vesicles to the plasma membrane (Heider and Munson, 2012)and references therein). The 
exocyst appears to function prior to SNARE assembly and vesicle fusion, as temperature-
sensitive (ts) mutants of individual exocyst subunits result in vesicle accumulation in the 
bud in yeast (Grote et al., 2000; Novick et al., 1980). In addition, the exocyst has been 
implicated in other essential membrane trafficking processes such as autophagy, 
ciliogenesis, and pathogen invasion, likely due to either a “hijacking” or relocalization of 
the exocyst’s putative tethering function (Bodemann et al., 2011; Farré and Subramani, 
2011; Nichols and Casanova, 2010). Although there is no high resolution structure of the 
entire complex, structures of domains of the individual exocyst subunits Sec6 (Sivaram et 
al., 2006), Sec15 (Wu et al., 2005), Exo70, and Exo84 (Dong et al., 2005; Hamburger et 
al., 2006; Moore et al., 2007) reveal that they are composed of evolutionarily conserved 
helical bundles, placing it into the CATCHR family. The remaining subunits are 
predicted to have similar structures (Croteau et al., 2009). 
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Consistent with a putative upstream tethering role, three of the eight exocyst 
subunits interact with lipids and small Rab and Rho family GTPases on the opposing 
membranes, although tethering has not yet been directly demonstrated (Adamo et al., 
1999; Baek et al., 2010; Brunet and Sacher, 2014; Guo et al., 1999; He et al., 2007; Wu et 
al., 2010; Yamashita et al., 2010; Zhang et al., 2001; 2008). The exocyst also interacts 
with the SM protein Sec1 through its Sec6 subunit (Morgera et al., 2012; Wiederkehr et 
al., 2004). Currently, no loss-of-binding mutants exist to test the function of the 
Sec1:Sec6 interaction in vivo, but work in our lab and others suggests that this interaction 
takes place in the context of the whole exocyst complex (Morgera et al., 2012; 
Wiederkehr et al., 2004). The exocyst also interacts with Sec2, the GEF for the vesicle-
specific GTPase Sec4, through its Sec15 subunit (Medkova et al., 2006). Finally, Sec6 
has been shown to interact with both the t-SNARE Sec9 and the v-SNARE Snc2 (Shen et 
al., 2013; Sivaram et al., 2005). Together, these indicate that the exocyst participates in 
the same set of interactions common to almost all tethering complexes, as detailed above.  
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Tethering Complex-SNARE Complex Interactions 
Interactions between tethering factors and SNARE complexes have been observed 
for almost all trafficking steps, and generally serve to promote formation of proper and 
stable SNARE complexes (Hong and Lev, 2014). However, only a few of these steps 
have been studied in enough detail to begin to understand the mechanism by which these 
interactions regulate SNARE complex assembly (summarized in Table 1.1). Work on 
well-established systems such as HOPS and COG suggests a common mechanism of 
action for the tether-SNARE interactions, despite the low structural similarities between 
CATCHR and non-CATCHR tethering factors. 
The HOPS complex interacts with many of the individual SNARE proteins, and 
the assembled SNARE complex, required for endosomal/lysosomal fusion (Krämer and 
Ungermann, 2011; Lobingier and Merz, 2012; Lürick et al., 2015; Stroupe et al., 2006). 
These interactions are important for several levels of regulation. First, HOPS recruitment 
by the t-SNARE Vam7 maintains proper HOPS localization at sites of vacuole fusion, 
and loss of Vam7 membrane binding results in reduced HOPS enrichment; this suggests 
that SNARE proteins enrich HOPS at sites of vacuole fusion (Wang et al., 2003). 
Secondly, HOPS is required to recruit the t-SNARE Vam7 to sites of fusion after 
disassembly of post-fusion SNARE complexes; these two interactions together result in a 
positive feedback enrichment of the various fusion machinery (Zick and Wickner, 2013). 
Thirdly, HOPS competes with the disassembly machinery (Sec17/Sec18) for binding to 
the assembled SNARE complex and preferentially binds to trans-SNARE complexes; this 
protects the pre-fusion trans-SNARE complex from disassembly (Collins and Wickner, 
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2007; Collins et al., 2005; Xu et al., 2010). Finally, HOPS has a higher affinity for 
properly-formed SNARE complexes than for non-cognate SNARE complexes, 
suggesting that it may “proofread” the SNARE complex prior to fusion (Starai et al., 
2008). This suggests that HOPS is important in all stages of SNARE assembly.  
Although less well characterized, COG:SNARE interactions operate using similar 
mechanisms of SNARE regulation as the HOPS:SNARE interactions (Kudlyk et al., 
2012; Laufman et al., 2009; 2011; 2013; Shestakova et al., 2007; Suvorova et al., 2002; 
Willett et al., 2013a). Knockdown of individual COG subunits in mammalian cells leads 
to an increase in uncomplexed SNAREs, changes in SNARE localization, and a decrease 
in overall SNARE stability (Fotso et al., 2005; Oka et al., 2004; Shestakova et al., 2007). 
Re-localization of the COG complex results in a relocalization of Golgi-destined vesicles, 
suggesting that a properly localized COG complex is required to recruit the proper 
vesicles to their sites of fusion (Willett et al., 2013a). Interestingly, COG has a higher 
affinity for the assembled SNARE complex than the individual SNAREs, suggesting a 
mechanism of protection similar to that of HOPS (Shestakova et al., 2007). Also similar 
to HOPS, regulation of SNARE pairing relies on interactions with the SM protein Sly1 
(Laufman et al., 2009; Willett et al., 2013a); the Vps33 SM subunit of HOPS mediates 
many of the HOPS:SNARE interactions (Baker et al., 2015; Lobingier and Merz, 2012; 
Lürick et al., 2015).  
While the mechanisms have not been as thoroughly tested for the remaining 
tethering complexes, they all have been shown to interact with their cognate SNAREs 
with the exception of the TRAPP complexes. CORVET interacts with 
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endosomal/vacuolar SNARE proteins and SNARE complexes through the Vps33 subunit 
it shares with HOPS (Balderhaar et al., 2013; Subramanian et al., 2004). The Dsl1 
complex interacts with t-SNARE proteins on the ER, potentially in lieu of interactions 
with small GTPases, and functional Dsl1 subunits are required for formation of the 
assembled t-SNARE complex (Kraynack et al., 2005; Meiringer et al., 2011). Finally, the 
GARP complex interacts with the N-terminal regulatory domain of the syntaxin homolog 
Tlg1, as well as the SNARE domains of several mammalian Golgi SNAREs. The 
mammalian GARP homologue also interacts with the assembled SNARE complex, and 
SNARE assembly is reduced when GARP is depleted (Conibear et al., 2003; Pérez-
Victoria and Bonifacino, 2009; Siniossoglou and Pelham, 2001; 2002). Together, these 
interactions suggest an overall positive role for the tether-SNARE interactions in 
promoting proper SNARE assembly prior to vesicle fusion. 
The outlier to this model for tether-SNARE interactions was the exocyst complex. 
The exocyst subunit Sec6 interacts with two SNARE proteins – the t-SNARE Sec9, and 
the v-SNARE Snc2. The Snc2 interaction may function in recruitment of the exocyst to 
sites of secretion, as mutants in Snc2 which disrupt the interaction with Sec6 result in a 
mild depolarization of the exocyst complex, and a general growth defect (Shen et al., 
2013). The interaction with Sec9, however, was suggested to be a negative regulator of 
SNARE assembly in vitro (Sivaram et al., 2005); this was in direct contrast to all other 
known tether:SNARE interactions, and meant the exocyst did not fit into the emerging 
model of tether:SNARE interactions. I therefore sought to dissect the seemingly 
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inhibitory Sec6:Sec9 interaction, and determine if reducing the rate of SNARE complex 
assembly is the function of this interaction in vivo.  
 
  
Table 1.1 – Summary of tether/SNARE interactions. The functional implications of the various tether-SNARE 
interactions in yeast and mammalian cells are summarized above. Anywhere “unknown” is present in the SNARE 
interaction field, it represents a functional consequence on the SNAREs without a known binding partner. Where the 
function is “unknown,” it means a binding interaction has been identified but not characterized 
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CHAPTER II: THE EXOCYST SUBUNIT SEC6 
INTERACTS WITH ASSEMBLED EXOCYTIC SNARE 
COMPLEXES 
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Significant Background and Experimental Rationale 
Our lab previously showed that the yeast exocyst subunit Sec6 interacts with the 
C-terminal SNAP-25 domain of the plasma membrane t-SNARE Sec9 (Sec9CT; residues 
414-651). This interaction was identified by an in vitro pull-down using GST-Sec9 and 
purified full-length Sec6 (Sivaram et al., 2005). Subsequently, we showed that the 
interaction also occurs in whole cell lysate by a co-precipitation assay using an HA-
tagged Sec6 construct and both endogenous and over-expressed levels of Sec9. 
Additional lysate gel filtration experiments suggested that the Sec6:Sec9 interaction takes 
place outside the assembled exocyst complex, as the majority of the Sec9 identified was 
found at a lower molecular weight than the exocyst (Morgera et al., 2012).  
The identification of this binary interaction led to the hypothesis that the exocyst, 
like other MTCs, participates in assembly of the exocytic SNARE complex. As discussed 
in Chapter I, the assembly of the SNARE complex proceeds in two stages – the t-
SNAREs assemble into a binary “acceptor” complex, and the v-SNARE is then 
incorporated upon vesicle arrival to provide the energy for membrane fusion. In budding 
yeast exocytic trafficking, the t-SNARE Sso1 adopts an auto-inhibited conformation prior 
to binary complex assembly; this results in in vitro assays reporting a non-physiological 
rate of assembly, with complete complex assembly taking 72+ hours (Munson and 
Hughson, 2002; Munson et al., 2000; Nicholson et al., 1998). Our lab and others have 
proposed the presence of an opening factor that would allow assembly to proceed at a 
more physiologically relevant rate, and upon discovery of the Sec6:Sec9 interaction it 
was proposed that Sec6 may provide that function. However, when the effect of Sec6 was 
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tested on the rate of SNARE assembly Sec6 appeared to inhibit, rather than promote or 
stabilize, in vitro formation of the Sso1:Sec9 binary SNARE complex - the rate of 
assembly, as measured by an in vitro gel filtration assembly assay, was four-fold slower 
in the presence of Sec6 (Sivaram et al., 2005). Therefore, our lab proposed that the 
Sec6:Sec9 interaction prevented premature assembly of the Sso1:Sec9 SNARE complex, 
and that assembly of the exocyst complex would recruit Sec6 and release Sec9 to form 
fusogenic SNARE complexes. In order to test these hypotheses, I sought to disrupt the 
Sec6:Sec9 interaction through mutagenesis of specific binding site residues. These 
residues were selected to avoid disrupting other critical protein-protein interactions that 
Sec6 or Sec9 participate in, and the mutant proteins were then used to test the importance 
of this interaction in vivo. 
Prior to formation of the assembled SNARE complex both Sec9 and Snc2 (the v-
SNARE for exocytosis) are intrinsically disordered proteins (IDPs), and adopt their 
helical conformations upon complex formation (Fasshauer et al., 1997; Nicholson et al., 
1998; Rice et al., 1997). IDPs are an intriguing challenge for biology – it is becoming 
increasingly apparent that many important regulatory proteins contain some degree of 
disordered sequence, yet current structural biology methods that rely on detection of 
static structures are often unable to capture the binding state of these proteins (Jurneczko 
et al., 2012; Tompa and Fuxreiter, 2008; Wright and Dyson, 2015). Additionally, due 
their inherent binding “fuzziness,” individual mutations are often unable to disrupt the 
native binding state of an ordered-disordered protein interaction as the disordered protein 
may use multiple low-affinity binding interactions in lieu of one tight binding site. This 
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makes it difficult to use systematic mutagenesis approaches to identify the critical 
binding residues (Uversky, 2002; 2013b; 2013a; Wright and Dyson, 2015).  
Therefore, because Sec9 is an IDP, the process of identifying the critical residues 
for the Sec6:Sec9 interaction was not straightforward. Additionally, previous studies to 
identify a minimal region of Sec9 necessary for the interaction with Sec6 found that the 
linker region between the two SNARE domains was required; further characterization, 
including limited proteolysis and truncation experiments, was hindered by the protease 
sensitivity of Sec9 (Sivaram et al., 2005).  Identification of the minimal binding region of 
Sec6 was similarly hindered, this time by the insolubility of the N-terminal domain of 
Sec6. While the C-terminal domain is fully soluble, and has a solved crystal structure 
(Sivaram et al., 2006), it was shown to be insufficient for binding; the insolubility of the 
N-terminal domain meant it was not possible to determine if that region was sufficient for 
binding (Sivaram et al., 2005).  
I therefore chose to use a chemical cross-linking and tandem mass spectrometry 
approach to define residues necessary for the Sec6:Sec9 interaction. This would allow for 
identification of specific binding site residues, and also provide information about how an 
ordered partner interacts with an IDP in the presence of a crosslinker. These experiments 
highlighted a patch of residues in the linker region of Sec9 that, when mutated, caused a 
mild exocytic trafficking defect. These residues are not necessary for the Sec6:Sec9 
direct interaction, but are required for a novel Sec6:SNARE complex interaction. The 
identification of this interaction required re-evaluation of the existing inhibition of 
SNARE assembly data, and I found that the previous data were misinterpreted - Sec6 
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does not reduce the rate of SNARE assembly to the extent previously observed. This 
novel interaction, together with the re-evaluation of the SNARE complex assembly data, 
suggest that the Sec6:Sec9 interaction may serve to positively regulate SNARE complex 
assembly similar to other MTC:SNARE interactions.  
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Results 
The Sec6:Sec9 interaction has low micromolar affinity 
 The first step in identifying loss-of-binding mutants for the Sec6:Sec9 interaction 
was to characterize the wild-type interaction, specifically the dissociation binding 
constant (Kd). Having a precise value would allow us to more precisely design 
experiments where we needed to use concentrations well above or well below the Kd. 
Previous attempts to determine this constant relied on gel filtration experiments, and were 
not able to narrow it down further than the 0.5 – 1.0 µM range (Sivaram et al., 2005). We 
therefore designed a surface plasmon resonance (SPR) experiment to determine the 
precise Kd for the interaction.  
 The C-terminal SNAP-25 domain of Sec9 was immobilized on a CM5 biacore 
sensor chip using the cross-linker EDC and stabilizing agent NHS to a final level of 500 
Figure 2.1 – Determination of the Sec6:Sec9 Kd by SPR. Sec9 was immobilized on a CM5 carboxydextran chip, and 
Sec6 was flowed over at varying concentrations. The RU value just prior to the buffer flow was then fit with a total 
binding curve containing a variable for linear non-specific binding, and the Kd was determined from the curve fit. This 
is the data from three separate flows over the same immobilized Sec9 followed by NaOH regeneration between 
experiments. 
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Response Units (RUs). This level of immobilized protein has been previously shown to 
be sufficient to detect binding (C. Painter, personal communications). Sec6 was then 
flowed over immobilized Sec9 in three separate experiments, and the saturation level of 
protein was detected at eight different protein concentrations from 0.1-13 µM (Figure 
2.1A). The resulting saturation point for each concentration was fit to a total binding 
curve with a constant for non-specific binding, and we determined the Kd to be  1.2 ± 0.2 
µM with a non-specific contribution of 3.6 RUs per µM of Sec6 (Figure 2.1B). These 
numbers are on the upper edge of the range determined by gel filtration (0.5 – 1.0 µM). 
There were, however, technical difficulties with the instrument and therefore the 
experiment could not be repeated with a different chip for confirmation of the calculated 
values.  
 
Sec6 specifically cross-links to the IDP Sec9, which identifies potential binding 
residues  
Once we identified the precise Kd of the interaction, we sought to examine the 
function of the Sec6:Sec9 interaction in vivo by generating specific loss-of-binding 
mutants in Sec9. Therefore, we needed to identify the residues necessary for the binding 
interaction. We chose to use the chemical cross-linker EDC followed by mass 
spectrometry analyses to map this interaction; this would allow us to circumvent 
difficulties caused by the flexible nature of the IDP Sec9. Chemical cross-linkers create 
covalent bonds between side chains (usually Lys-Lys or Asp/Glu-Lys) separated by 
specific distances; EDC reacts with Asp/Glu and Lys residues that are in close proximity 
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and creates a peptide bond between the free carboxyl and free amine groups. Purified 
Sec6 and Sec9 were mixed together, cross-linked by EDC (+/- NHS or Sulfo NHS to 
stabilize the cross-linker), and a portion of the total reaction was quenched at various 
time points (1-120 min, depending on the experiment). The reaction from each time point 
was run on SDS-PAGE and the band corresponding to the 1:1 Sec6:Sec9 complex was 
excised, trypsinized, and subjected to LC/MS mass spectrometry by varying collision 
methods. A list of all crosslinks identified is presented in Table 4.1 (Appendix A), along 
with the experiment in which they were identified and the crosslinking class they were 
assigned to. The identified cross-linked peptides mapped across the entire length of Sec9 
(36 residues out of 63 total Glu/Lys/Asp residues) and Sec6 (68 residues out of 200 total 
Figure 2.2 - EDC cross-linking results in a large dataset. All of the cross-links identified in each of the experiments 
described in the Experimental Procedures were mapped onto the C-terminal structure of Sec6 (aa 411-805) and linear 
segments representing the N-terminal domain of Sec6 and the SNARE domains of Sec9. Grey boxes indicate helical 
secondary structure – the known SNARE helices on Sec9, and the predicted helical regions of the Sec6 (aa 1-410) 
(SOPM algorithm, (Rost et al., 2004)). 
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Glu/Lys/Asp residues; all Glu/Lys/Asp residues in the Sec6 C-terminal domain are 
located on the surface (Sivaram et al., 2006)), with 152 unique cross-links between them 
(Figure 2.2). This large number of cross-links was expected due to the flexible nature of 
the IDP Sec9. However, only ~50% of the available Asp/Glu/Lys residues on Sec9 and 
only ~35% of the Asp/Glu/Lys residues on Sec6 were identified as participating in a 
cross-link (Figure 2.3), indicating that the cross-linking reaction was not random.  
 Due to the large number of cross-links identified, we sought to limit our analysis 
to only those likely involved in the binding interaction. Because this experiment was 
carried out as a time course, we categorized each cross-link based on presence/absence 
and intensity at different time points (Figure 2.4A). These analyses identified two classes 
of cross-links: those that had constant intensities over time, and those whose intensities 
changed over time. The constant intensity cross-links are ones that form early in the 
Figure 2.3 – Sec6 and Sec9 specifically cross-link. All possible cross-linkable residues (lysine, blue; glutamic 
acid/aspartic acid, red) are mapped onto the proteins as in Figure 2.2 
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reaction, and those that are more variable form later as cross-links that are secondary to 
the “early-forming” cross-links (Figure 2.4B). We hypothesized that residues 
participating in salt bridges in the binding interface are initially protected from EDC; 
thus, the early-forming cross-links lie outside the core of the protected binding site. After 
formation of the early cross-links, the now-limited flexibility of the IDP Sec9 and low 
micromolar affinity of the Sec6:Sec9 interaction will result in disruption of some of the 
salt bridges, allowing those residues to participate in “late-forming” cross-links. Some 
residues are capable of participating in both early and late-forming cross-links, likely due 
to the bulk nature of this assay and the variable accessibility of those residues due to the 
flexibility of Sec9. 
Figure 2.4 - Cross-linking over a time-course results in two classes of cross-linked peptides. A) At each time point 
in the cross-linking reaction (0-120min, depending on experiment), a portion of the reaction was quenched and the 
cross-linked peptides identified/quantified by mass spectrometry. The resulting cross-links were grouped into two 
classes – “early-forming” cross-links (top panel) that form early in the reaction and do not change intensity over time, 
and “late-forming” cross-links (bottom panel) that increase in intensity over time. B) A model for how an intrinsically 
disordered protein may interact with a well-folded binding partner over time in the presence of EDC. (1) Sec9 binds to 
Sec6 and this interaction (red circle) protects binding site residues from EDC. (2) Early-forming cross-links (yellow) 
form as chemically capable side chains come into contact. (3) Equilibrium dissociation of the local interaction occurs; 
early forming cross-links (yellow) force the proteins to remain in close proximity despite loss of the original interaction 
(red). (4) Late forming cross-links (blue) form as chemically capable side chains come into contact through random 
motion of Sec9– these new cross-links can occur in the binding site (bottom), or outside the binding site (top). 
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Based on these hypotheses, we focused on residues that participate in late-forming 
cross-links, specifically those that are located nearby early-forming cross-links (Figure 
2.5, red circle). After filtering the data set accordingly, we identified a five amino acid 
stretch on Sec9 that satisfied the above conditions – the first (Lys-533) and last (Glu-537) 
residues cross-link to adjacent regions on the Sec6 C-terminal domain (Sec9 Lys-533 to 
Sec6 Glu-447, Sec9 Glu-537 to Sec6 Lys-516), and these cross-links are nearby early-
forming cross-links (Lys-531 and Lys-532 on Sec9). The intervening residues contain a 
mixture of hydrophobic and electrostatic side chains that are incapable of forming cross-
links (Leu-534, Met-535, Arg-536). These residues lie in the middle of the 80-90 residue 
linker region of Sec9, between the two regions that will fold into the SNARE motif 
helices upon SNARE assembly; therefore, mutations in these residues will not disrupt the 
Figure 2.5 – Cross-linking time course highlights residues likely necessary for the interaction. Cross-linked 
residues are colored based on the classes of cross-links (“early-forming”, yellow; “late-forming”, blue; combination 
residues that participate in both classes, green). Only cross-links between “late-forming” residues are shown. Based on 
the model in Figure 2., residues likely involved in the binding interaction are circled in red. The sec9-142 mutation is 
located between two blue residues (Lys-533 and Glu-537) in the circle. 
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stability of the assembled SNARE complex. Additionally, previous studies suggested that 
this region may be important for the Sec6:Sec9 interaction (Sivaram et al., 2005). To 
generate a mutant sec9 allele for studying the importance of these residues in the 
Sec6:Sec9 interaction, the entire stretch was mutated to oppositely charged residues 
generating the sec9-142 allele (Lys-533 to Glu, Leu-534 to Glu, Met-535 to Glu, Arg-536 
to Glu, and Glu-537 to Arg).  
 
The sec9-142 allele causes growth defects in sensitized backgrounds, but does not 
disrupt Sec6:Sec9 direct binding  
To test the effect of the sec9-142 allele, we integrated the mutant into the 
endogenous locus in otherwise wild-type yeast and tested if it could function as the sole 
copy of SEC9. We predicted that the interaction between Sec6 and Sec9 is necessary, and 
that disruption of the interaction would result in a growth defect due to disruption of the 
secretory pathway. After a serial dilution assay to compare the growth of wild-type and 
sec9-142 yeast at various temperatures (23-37 °C) (WT vs sec9-142; Figure 2.6), we 
found no observable differences between the two strains.  This suggests that the mutant 
protein is sufficient for growth under otherwise wild-type conditions.  
Despite not having a growth defect, the sec9-142 strain may still have a mild 
disruption in the exocytic pathway that will be exacerbated when combined with other 
mutations in the secretory pathway. To test for such synthetic effects, we replaced the 
wild-type SEC9 gene with the sec9-142 allele in temperature sensitive (ts) strains that 

 39 
0.1 µM, and 0.01 µM), and the 
extent of binding by a GST pull-
down assay was quantified as a 
fold change over binding to GST 
alone. We found that Sec6 binds to 
both GST-Sec9 and GST-Sec9-142 
significantly over background at 
all concentrations tested except 
5.00 µM (Figure 2.7), but detected 
no significant differences in 
binding between the two Sec9 
constructs. This is likely due to the 
capability of an IDP to bind to an 
ordered partner with multiple low-affinity binding sites, and our disruption of only one of 
those sites (Uversky, 2002; 2013b; Wright and Dyson, 2015). Therefore, further tests of 
this interaction necessitate either generation of more mutants, or testing the Sec9-142 
protein in a functional test that requires the Sec6:Sec9 interaction. 
 
Sec6 does not affect the rate of SNARE assembly in vitro  
While we could detect no significant loss of the Sec6:Sec9 interaction, the 
function of Sec6 as a SNARE assembly inhibitor may be impacted by the Sec9-142 
protein, resulting in the observed synthetic growth defect. To further investigate this, we 
Figure 2.7 - The sec9-142 mutant does not disrupt Sec6:Sec9 direct 
binding. The indicated concentration of Sec6 was incubated with 25 
nM GST-protein, immobilized on glutathione magnetic resin, and the 
fold change over GST-alone binding was quantified. The differences 
between all pairwise interactions were determined by a one-way 
ANOVA test on non-matched parametric data with Holm-Sidak 
correction for multiple comparisons in GraphPad Prism. n=3, graphed 
as mean + S.E. *p ≤ 0.05, **p ≤ 0.01, ****p ≤ 0.001.  
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tested the effect of Sec9-142 on SNARE complex assembly in vitro. Our earlier studies 
had shown a decreased rate of SNARE assembly (~4-fold) as monitored by gel filtration 
chromatography in the presence of Sec6, as well as reduced levels of assembled SNARE 
complexes using a native gel mobility shift assay; therefore, if this mutant disrupted the 
inhibitory function of Sec6, there should be no difference between the conditions with or 
without Sec6 when combined with the Sec9-142 mutant (Fasshauer et al., 1997; 
Nicholson et al., 1998; Rice et al., 1997).  
To test if the Sec9-142 protein is sufficient to remove the inhibition of Sec6 on 
SNARE assembly, we adapted the previous native gel mobility shift assay to measure the 
t-SNARE assembly rate. Previously, these experiments were run on thin, upright, native 
gels (pH 7.4); due to the lack of a stacking layer, both the SNARE complex band and the 
uncomplexed Sso1 band were inconsistently resolved. We modified the assay to use a 
“slab” gel (a thicker, 0.5-1.0 cm polyacrylamide gel polymerized in a horizontal gel box) 
and lowered the pH of the gel (pH 6.6). These modifications resulted in sharper 
resolution of the free Sso1 band. The experiment was run with seven time points 
incubated for up to 72 h, as required by the slow nature of in vitro SNARE assembly with 
the autoinhibited form of Sso1, and the resulting decreased intensity of the uncomplexed 
Sso1 bands over time was fit to an integrated second order rate equation (Hayashi et al., 
1994; Söllner et al., 1993).  
This modified assay was used with various combinations of proteins (Sec9+Sso1, 
Sec9-142+Sso1, Sec9+Sso1+Sec6, and Sec9-142+Sso1+Sec6) to determine if Sec9-142 
affected the rate of SNARE complex assembly. First, we tested if the Sec9-142 mutant 
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protein has a defect in SNARE assembly by comparing the rates of assembly of the 
mutant and wild-type Sec9 in the absence of Sec6. After quantification of the free Sso1 
band (Figure 2.8A, top left vs. top right panel, and Figure 2.8B, light blue vs. yellow 
curves), the rate (k) of assembly of SNAREs containing Sec9-142 was within two-fold of 
those containing wild-type Sec9 (1.7 ± 0.4 M-1s-1 for Sec9-142 vs. 0.88 ± 0.3 M-1s-1 for 
Sec9). This difference in rate can be attributed to potential differences in concentration of 
the two Sec9 constructs. We therefore concluded that Sec9-142 does not have an 
appreciable effect on the rate of binary SNARE complex assembly. We next tested 
whether Sec6 was able to inhibit formation of Sec9-142 containing SNARE complexes. 
Unexpectedly, we did not observe an inhibition of SNARE complex assembly by Sec6 
with either Sec9 or Sec9-142, despite a potential decrease in the intensity of the 
assembled SNARE complex band (Figure 2.8A, bottom left vs. top left panel). When the 
Figure 2.8 - Sec6 does not affect the rate of SNARE assembly. The cytoplasmic domain of Sso1 and the SNAP-25 
domain of Sec9 (WT or Sec9-142) were incubated together at 10 µM for 0-72 h with or without equimolar Sec6, and 
resolved on a pH 6.6 Histidine-MOPS polyacrylamide native gel. The free Sso1 band was quantified and fit to an 
integrated 2nd order rate equation, assuming equal concentrations of reactants as previously described (11). A) 
Representative native gels showing the assembled SNARE complex band and free Sso1 band, which was quantified; * 
denotes the non-resolved Sec9 band, and non-specific contaminants from the Sec9-142 prep, and ** denotes a 
contaminant from the Sec9 prep. B) Quantification of the native gel assays, fit to the integrated 2nd order rate equation 
assuming equal concentration of reactants. Data from four replicates were globally fit and the rate constants are 
reported ± S.E. of the fit (GraphPad Prism).  
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loss of uncomplexed Sso1 over time was quantified (Figure 2.8B), there was no 
appreciable difference between any of the conditions tested (Sec9, k = 0.88 ± 0.1 M-1s-1; 
Sec9-142, k = 1.7 ± 0.4 M-1s-1; Sec9+Sec6, k = 0.91 ± 0.3 M-1s-1; Sec9-142+Sec6, k = 1.4 
± 0.4 M-1s-1). Curiously, the extent of the reaction appears different in the Sec9+Sec6 
condition: at t = ∞, ~30% of Sso1 is calculated to remain unbound when Sec6 is present, 
while <5% of Sso1 is calculated to remain unbound in the other conditions. Therefore, 
Sec6 does not appear to affect the rate of SNARE assembly, but may be affecting the 
final equilibrium between the proteins; e.g., SNARE complex assembly may not be able 
to proceed to completion due to Sec6 sequestering a fraction of Sec9, but not Sec9-142. 
Several explanations could be responsible for the differences between these results and 
the previous ones, including the fact that the earlier quantifications were performed on 
samples analyzed by gel filtration chromatography rather than native gels. To understand 
these conflicting results, we sought to determine if the differences in experimental design 
were responsible for the discrepancies, and if one or both experiments were 
misinterpreted.  
 
Gel filtration chromatography cannot fully resolve uncomplexed Sec6 and Sso1 
peaks 
To examine differences between the gel filtration and native gel SNARE 
assembly assays, we repeated the gel filtration assay as previously described (McNew et 
al., 2000). In this assay, we monitored SNARE complex assembly by a loss of the 
uncomplexed Sso1 A280 peak. The free Sso1 peak heights in this experiment appeared 
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similar to our previous findings (Figure 2.9A, (Izawa et al., 2012)). However, when we 
examined the entirety of the gel filtration profiles, we found that the previous analyses 
did not account for the contribution of uncomplexed Sec6. Sec6 elutes as a non-
symmetrical peak on a gel filtration column, with a right-hand tail, and overlaps with the 
free Sso1 peak.  This causes an increase in the Sso1 peak height when Sec6 and Sso1 are 
run together compared to Sso1 alone (Figure 2.9B, blue trace vs red trace). When Sec9 
is incubated with Sec6 and Sso1, Sec9 binds Sec6 and the Sec6:Sec9 complex migrates 
as a larger complex that has little to no overlap with the free Sso1 peak (Figure 2.9B, red 
trace). As SNARE complex assembly proceeds, Sec6 is released and its peak shifts back 
to the uncomplexed position; this results in increased overlap with the free Sso1 peak 
(Figure 2.9B, red/orange/yellow traces) and an increase in the apparent Sso1 peak height 
at later time points. Additionally, due to the propensity of Sec6 to aggregate over time, a 
fraction of it can be found in a peak that exits near the void volume of the column; Sso1 
and Sec9 are also found in this aggregate peak, which affects our ability to quantify the 
amount of free Sso1. Thus, quantification of Sso1 peak heights in the presence of Sec6 
may have previously led to an erroneous interpretation of the rate of binary SNARE 
assembly.  
To circumvent the overlapping peaks problem in the gel filtration experiments, we 
quantified changes in the amount of free Sso1 in the eluted free peak using protein gels. 
The three fractions that correspond to the top of the free Sso1 peak from each time point 
were run on SDS-PAGE gels. All proteins were then detected with high-sensitivity 
Krypton fluorescent protein stain (Figure 2.9C) and the free Sso1 band was analyzed to 
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determine the kobs for the loss of free Sso1 (Figure 2.9D). This rate is faster than that 
measured by native gel in Figure 2.8 (0.49 ± 0.4 M-1s-1 for Sec9, 0.58 ± 0.3 M-1s-1 for 
Figure 2.9 - Sec6 leads to an artificial apparent increase in the free Sso1 peak by gel filtration over time. A) The 
binary Sec9:Sso1 SNARE complex assembly assay +/- Sec6, as monitored by gel filtration, showing the free Sso1 peak 
height. As previously reported {Sivaram:2005hg}, quantification of this peak led to the conclusion that Sec6 was 
inhibitory to SNARE complex assembly. B) Analysis of the full peaks, including an equimolar Sso1+Sec6 control, 
demonstrates that uncomplexed Sec6 leads to an apparent increase in the free Sso1 peak relative to Sso1 at 0 h. C) The 
three fractions corresponding to the free Sso1 peak (denoted under the Sso1 curve in B) were resolved on SDS-PAGE, 
and stained with Krypton protein stain (Pierce). Shown is a representative gel set from gel filtration experiments in the 
absence of Sec6. D) The bands in C and the other gels were quantified by densitometry, and normalized to the band at t 
= 0. These values were analyzed together and globally fit to an integrated 2nd order rate equation 
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Sec9+Sec6), but with larger errors. Despite the differences, these data agree that the 
presence of Sec6 does not appreciably decrease the rate of SNARE complex assembly.  
 
Sec6 binds both the binary and ternary SNARE complexes, and this interaction is 
significantly reduced by Sec9-142  
Our results above resolved the difference between our current data and those 
previously published (Sivaram et al., 2005). However, they did not provide insights into 
the nature of the Sec6:Sec9 interaction in vivo. We therefore tested whether, as observed 
for other MTC-SNARE complex pairs (Brennwald et al., 1994), Sec6 could bind to 
binary Sec9:Sso1 or ternary Sec9:Sso1:Snc2 SNARE complexes, and if Sec9-142 was 
sufficient to disrupt that interaction. As before with the Sec6:Sec9 interaction, we used 
multiple concentrations of Sec6 (0.05, 0.5, and 5.0 µM) and a low fixed concentration of 
SNAREs (25 nM), to maximize the signal from the bound complex. At concentrations 
much higher or much lower than the equilibrium dissociation concentration (Kd), the 
signals will not be significantly different between various conditions due to the absence 
of binding at low concentrations and increased background binding at high 
concentrations. At concentrations of Sec6 closer to the Kd, differences in signal will be 
more readily observable. For each binding reaction, the molar ratio of Sec6:GST-protein 
was normalized to the GST background signal, and all related conditions were tested for 
significant differences in binding (one-sided ANOVA with multiple comparisons on non-
matched data sets).  
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We chose to test the following constructs for Sec6 binding: GST and GST-Sso1 
as negative controls, GST-Sso1:Sec9 and GST-Sso1:Sec9-142 to test binding to the 
binary SNARE complex, and GST-Sso1:Sec9:Snc2 and GST-Sso1:Sec9-142:Snc2 to test 
for binding to the ternary SNARE complexes. All Sso1-containing constructs were 
formed using just the SNARE domain (Sso1-Ctb) to maximize purification of assembled 
SNARE complexes. As predicted, the binding of Sec6 to SNARE complexes at 
concentrations ~5-10 fold above (Figure 2.10, 5 µM, left panel) or below (Figure 2.10, 
0.05 µM, right panel) the approximate Kd of the Sec6:Sec9 interaction showed no 
significant difference over 
background in any of the 
conditions tested.  
When the GST-
SNAREs were incubated at 
concentrations near the Kd 
(Figure 2.10, 0.5 µM, 
center panel), the amount of 
Sec6 bound to SNARE 
complexes was 
significantly higher than to 
GST alone. Sec6 bound 
both binary GST-Sso1:Sec9 
(light green bar) and 
Figure 2.10 - Sec6 binds both the binary and ternary SNARE complex. 
Sec6, at the listed concentrations, was incubated with 25 nM GST and GST-
SNAREs (GST-Sso1CTb, GST-Sso1CTb:Sec9 or binary SNAREs, GST-
Sso1CTb:Sec9:Snc2 or ternary SNAREs). The Sec6 protein that bound to the 
beads was quantified by densitometry of SDS-PAGE stained with krypton 
high-sensitivity protein stain. Each experiment is represented as the fold change 
over the GST-only background binding, and the differences between the 
pairwise interactions were determined by a one-way ANOVA statistical test on 
non-matched parametric data with Holm-Sidak correction for multiple 
comparisons in GraphPad Prism. n=3, graphed as mean plus S.E. *p ≤ 0.05, 
**p ≤ 0.01, ***p ≤ 0.005, ****p ≤ 0.001.  
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ternary GST-Sso1:Sec9:Snc2 (light pink bar) SNARE complexes over background (p ≤ 
0.005). Additionally, there was a significant increase in Sec6 binding to ternary 
complexes compared to binary complexes, indicating that Sec6 has a greater affinity for 
the ternary than the binary complex (p ≤ 0.005, light green vs. light pink bars). Finally, 
the binding to binary and ternary SNARE complexes containing Sec9-142 was 
significantly decreased (p ≤ 0.05 for binary SNARE complexes, light green vs. dark 
green bars, and p ≤ 0.001 for ternary SNARE complexes, light pink vs. dark pink bars). 
Neither binary nor ternary SNARE complexes containing Sec9-142 bound Sec6 
significantly over the GST background. These data demonstrate that Sec6 binds both the 
binary and ternary SNARE complexes. Furthermore, binding of Sec6 to SNARE 
complexes requires residues in the linker region of Sec9, as the interaction is abrogated in 
the presence of Sec9-142. Additionally, they demonstrate how the folded and disordered 
forms of Sec9 vary in their ability to bind Sec6 – while the disordered protein was able to 
compensate for the loss of the Sec9-142 binding site, the ordered protein in the assembled 
complex is either no longer able to compensate for those mutated residues, or other 
potential binding sites are occluded by the assembled complex. 
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Experimental Procedures 
Protein expression and purification  
 Mutations in recombinant proteins were generated by overlap extension PCR, 
cloned into the T7-expression vectors pET15b (Sec6 constructs) or pETDuet-1 (Sec9 and 
Sso1 constructs), and confirmed by sequencing. Full-length yeast Sec6(1-805), Sec9(414-
651), and the cytosolic domain of Sso1(1-265) proteins were overexpressed in 
BL21(DE3) or BL21(DE3) RIL E. coli cells and purified as described (Nicholson et al., 
1998; Sivaram et al., 2005). Protein concentrations were determined by a quantitative 
ninhydrin assay (Rosen, 1957). The C-terminal domain of Sec9 is homologous to the 
mammalian homolog SNAP-25 and was previously shown to be functional in yeast 
(Brennwald et al., 1994).  
 
Cross-linking and Protein Digestion  
 Sec6 and Sec9 were combined 1:1 (7 µM each) in a solution of 10 mM potassium 
phosphate buffer (pH 7.4), 140 mM KCl, and 4% glycerol and incubated for two hours at 
room temperature. EDC (1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride; 
Thermo Scientific) was then added at 1000x molar excess in 5 µL of 10 mM potassium 
phosphate buffer (pH 7.4). Variations on this reaction were also performed, to improve 
detection sensitivity: with the addition of either 500x molar excess NHS (N-
hydroxysuccinimide; Thermo), or 500x molar excess Sulfo-NHS (N-
hydroxysulfosuccinimide; Thermo), to increase the stability of the partially cross-linked 
complex; and at low concentrations of reactants (1 µM) to detect only early-forming 
 49 
crosslinks. The reaction proceeded for 15, 30, 60, and 120 min before quenching with 
Laemmli sample loading buffer (Bio-Rad) and boiling for 10 min. One additional 
experiment was run at 30 s, 1 min, 5 min, and 10 min to again detect only early-forming 
crosslinks. Approximately 15 µg of protein from each reaction was loaded and run on a 
4-20% Mini-PROTEAN TGX precast SDS gel (Bio-Rad). Bands corresponding to the 
monomeric Sec6:Sec9 cross-linked complex were excised and destained twice with 200 
µL 25 mM ammonium bicarbonate in 50% acetonitrile, reduced in 10 µL of 50 mM DTT 
for 10 min at 60 °C, then alkylated in 10 µL of 100 mM iodoacetamide for one h in the 
dark at room temperature. Proteins were digested overnight at 30 °C with 100 ng trypsin 
(Promega). Following digestion, peptides were transferred into a clean tube, and then 
further extracted twice with 50% acetonitrile containing 5% (v/v) formic acid. The 
combined extracts were dried in a SpeedVac and brought to 20 µL with 0.1% (v/v) 
formic acid for LC-MS/MS. 
 
LC-MS/MS  
 Peptide digests were injected (2 µL) and loaded at 4 µL/min (5% acetonitrile 
containing 0.1% formic acid) onto a custom packed trap column (100 µm I.D. fused silica 
with Kasil frit) consisting of 2.0 cm of 200 Å, 5 µm Magic C18AQ particles (Bruker-
Michrom) configured to a custom packed analytical column (75 µm I.D. fused silica) 
packed with 25 cm 100 Å, 5 µm Magic C18AQ particles (Bruker-Michrom) to a gravity-
pulled tip. Peptides were separated at 300 nL/min using a Proxeon Easy-nLC (Thermo 
Scientific) system using a linear gradient from 100% A (5% acetonitrile with 0.1% (v/v) 
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formic acid) to 35% B (acetonitrile with 0.1% formic acid) in 90 min and eluted directly 
into an LTQ Orbitrap Velos hybrid mass spectrometer (Thermo Scientific) (Olsen et al., 
2009). Data were acquired using a data-dependent acquisition routine of acquiring one 
mass spectrum from m/z 350-2000 in the Orbitrap (resolution 60,000) followed by 
tandem mass spectrometry scans of the 10 most abundant precursor ions found in the 
mass spectrum. Alternate runs collected either collision-induced dissociation (CID) or 
higher-energy collisional dissociation (HCD) spectra acquired in the Orbitrap mass 
analyzer. Data-acquisition utilized charge state rejection of singly, doubly, and triply 
charged ions, and dynamic exclusion was utilized to minimize data redundancy and 
maximize peptide identification (Olsen et al., 2009). 
 
Data Analysis 
 A concatenated peptide database was generated by xComb (University of 
Washington) software (Panchaud et al., 2010). The database considered all inter- and 
intramolecular Sec6 to Sec9 EDC-linked tryptic peptides up to 2 missed cleavages. The 
raw data was converted to peak lists and searched using the Sequest search engine 
contained in Proteome Discoverer (Version 1.3; Thermo Scientific). Briefly, no enzyme 
specificity was considered; parent ion tolerances were set to 15 ppm, fragment ion 
tolerances were set to 0.05 Da, methionine oxidation was considered as a variable 
modification, and carbamidomethylation of cysteine was considered as a fixed 
modification. The peptide results were then filtered by removing hits with an XCorr x Sp 
product less than 146. Label-free quantitation using peptide extracted ion chromatograms 
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(XIC) was done using ProteoIQ (Version 2.3.08; NuSep) quantitative analysis software 
using the replicate method (Radulovic et al., 2004). Cross-linked peptides with a 
precursor ion intensity of less than 1.0x105 from the mass spectrum in the 120-minute 
reaction time samples were filtered and removed from the dataset. For the generation of 
the crosslinking Figures 2.2, 2.3, and 2.5, all experimental designs were combined and 
examined together to determine the effect of the crosslinker on the Sec6:Sec9 complex. 
 
Effect of Sec9 mutations in vivo 
 The full-length sec9-142 (1-651) mutant gene was cloned into the yeast 
integration vector pRS306, linearized with EcoRI, and transformed into both BY4741 
and BY4742 ((Brachmann et al., 1998); Open Biosystems) using a yeast high efficiency 
transformation protocol (Gietz and Woods, 2002). The wild-type SEC9 and residuals 
from the pRS306 plasmid were selected against using 5-fluoroorotic acid (Sikorski and 
Hieter, 1989), and the mutations were confirmed by sequencing. Double mutant strains 
containing sec9-142 and exocytic temperature sensitive alleles were generated by mating 
the above sec9-142 strains to the exocytic temperature sensitive strains stated (Novick et 
al., 1980), sporulation, and confirmation by temperature sensitivity and sequencing of the 
sec9 locus. Growth defects were detected by a serial dilution assay, where log phase 
cultures were diluted to 1.0 OD600 units/mL. This culture was diluted 10-fold over 6 
samples, and dilutions were spotted onto plates containing YPD media and incubated for 
72 h at the indicated temperature. 
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SNARE complex assembly monitored by native gel mobility shift assay 
 Purified recombinant Sso1 (a.a. 1-265) was mixed with the indicated proteins at 
10 µM final concentration of each protein in a 15 µL final reaction volume of 10 mM 
sodium phosphate (NaPhos) pH 7.4, 200 mM sodium chloride (NaCl), 1 mM DTT and 
incubated at 18 °C for various times (0-72 h). 3 µL of 6x native gel loading dye (0.6% 
w/v bromocresol green, 30% v/v glycerol, 25 mM histidine, 30 mM MOPS) was added to 
each reaction in the cold room, and 5 µL was loaded on a 200 mL slab native PAGE gel 
at pH 6.6 (6.0% acrylamide, 25 mM histidine, 30 mM MOPS, 2.5% w/w glycerol, 
polymerized with 2.0 mL 10% w/v APS and 200 µL TEMED) that was pre-equilibrated 
for 1h at 4 °C. The gel was run for 4 h at 100 V at 4 °C in pH 6.6 native gel buffer (25 
mM histidine, 30 mM MOPS) (McLellan, 1982), and protein bands visualized by 
Coomassie blue staining (Wong et al., 2000). The percent free Sso1 was quantified by 
densitometry (Photoshop, CS5): the density of each band was divided by the Sso1 band 
from the zero time point. The resulting curve was fit using the derived second-order rate 
equation (Nicholson et al., 1998) using GraphPad Prism, with Y at t = 0 constrained to 
1.0 and Y at t = ∞ constrained to > 0. All four replicates were fit to a global rate constant, 
k, and presented as +/- the standard error of the fit as reported by GraphPad Prism. 
 
SNARE complex assembly monitored by gel filtration 
 All proteins were incubated together in 200 µL final volume at 10 µM final 
concentration in 30 mM NaPhos pH 7.4, 200 mM NaCl, 1 mM DTT for the indicated 
time (0-72 h), and injected on a Superdex 200 10/30 column (GE LifeSciences) pre-
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equilibrated in the same buffer. 200 µL fractions were collected from 0.41-0.71 column 
volumes (CV) and run on a 10% SDS-PAGE gel. Proteins were visualized by fluorescent 
Krypton staining (Pierce) and imaged on a Typhoon fluorescence stage with a 532nm 
laser (GE LifeSciences). Sso1 band intensities of the three fractions corresponding to the 
top of the A280 free Sso1 peak (0.61-0.63 CV) were quantified by densitometry 
(Photoshop CS5), and each fraction was plotted as a curve across the time course. Since 
the free Sso1 peak is approximately Gaussian, the resulting curves were fit using the 
derived second-order rate equation (Nicholson et al., 1998) as described above in 
GraphPad Prism with each curve fit to a global rate constant with the surrounding 
fractions (three in total) to control for loading error. A representative fit of two replicate 
experiments is shown, and the k value is presented as +/- the standard error of the fit as 
presented by GraphPad Prism. 
 
Sec6:Sec9 and Sec6:SNARE binding 
 GST-Sec9 and GST-Sec9-142 were purified by expression of each construct as 
previously described (Sivaram et al., 2005). GST-tagged binary and ternary SNARE 
complexes were purified by mixing E. coli lysates containing each of the individual 
components (Sec9CT, GST-Sso1CTb (residues 179-265), Snc2 (residues 1-92)), 
expressed as previously described (Nicholson et al., 1998), with a limiting concentration 
of GST-Sso1CTb. All GST-protein containing lysates were incubated for 1 h at 4 °C with 
glutathione agarose resin, washed in wash buffer without glutathione (50 mM Tris pH 
8.0, 150 mM NaCl, 10% glycerol, 0.5% IPEGAL, 3 mM DTT), and eluted in wash buffer 
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+ 40mM reduced glutathione. All constructs except GST-Sec9-142 were diluted 2-fold in 
10 mM HEPES pH 7.4, loaded onto a MonoQ 10/10 column (GE LifeSciences) pre-
equilibrated in 10 mM HEPES pH 7.4 and 100 mM NaCl, and eluted with a gradient 
from 100 mM – 1 M NaCl. Fractions containing the SNAREs were concentrated and 
frozen in 10 mM NaPhos pH 7.4, 140 mM NaCl. GST-Sec9-142 was diluted 30x in 
10mM Hepes pH 7.0, 150 mM NaCl, concentrated to 1 mL in an Amicon 10 KDa spin 
concentrator (Millipore), and frozen in 10 mM NaPhos pH 7.4. The final concentration of 
the protein was determined by a quantitative ninhydrin assay (Rosen, 1957). 
 To test for binding to Sec6, 25 nM GST-protein (or GST alone) were incubated 
with the indicated concentration of Sec6 in binding buffer (30 mM NaPhos pH 7.4, 200 
mM NaCl, 5% glycerol, 0.5% IPEGAL, 1 mM DTT) in a final volume of 100 µL for 1 h 
at 4 °C. 90 µL of the incubated proteins were added to 2 µL of magnetic glutathione resin 
slurry (Thermo Fischer, 25 % slurry) and incubated for an additional 1 h at 4 °C. The 
supernatant was removed, and the resin was re-suspended in 1x Laemmli loading buffer 
before being heated at 95 °C for 5 min. The beads were not washed prior to boiling to 
maximize the bound protein signal. 10 µL of each sample was loaded on a 12% SDS-
PAGE gel, and proteins were visualized by Krypton staining (Pierce) and imaging on a 
Typhoon fluorescence stage (GE LifeSciences). The extent of binding was measured by 
calculating the molar Sec6:GST-protein ratio (densitometry of Sec6 divided by the 
densitometry of the GST-protein, normalized for protein size), and dividing by the 
Sec6:GST molar ratio to normalize by background binding. Each bar represents three 
replicates ± standard error, and statistical significance was calculated using an ordinary 
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one-way ANOVA test with multiple comparisons corrected for by Holm-Sidak’s multiple 
comparisons test (GraphPad Prism).  
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CHAPTER III: DISCUSSION 
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Scientific Questions 
My studies sought to understand how the exocyst and its interaction with the 
SNARE protein Sec9 contribute to the regulation of SNARE complex assembly and 
vesicle fusion. Additionally, in a broader context we sought to understand how the 
exocyst fits into the emerging picture of other tethering factors; specifically, if the 
exocyst shares a common set of interactions with the other tethering complexes involved 
in protein trafficking.  
In terms of the various protein-protein interactions, the exocyst is a typical 
example of a tethering complex. It interacts with the Rab GTPase Sec4 on the vesicle 
membrane and the Rho GTPase Cdc42 on the target membrane (although evidence of a 
direct interaction with Sec4 has yet to be conclusively demonstrated), the SM protein 
Sec1, and the GEF Sec2. Like other tethering complexes, disruption of the exocyst results 
in an accumulation of vesicles prior to fusion. However, a major difference between the 
exocyst and other MTCs is in the exocyst’s interactions with SNARE proteins. Sec6, a 
component of the exocyst complex, interacts with both the v-SNARE Snc2 and the t-
SNARE Sec9. Although the interaction with Snc2 may be required for proper 
polarization of the complex, the interaction with Sec9 appeared to be inhibitory and 
reduced the rate of binary t-SNARE complex formation. This was in stark contrast to 
other tethering-SNARE interactions, which are primarily involved in stabilizing the 
SNARE proteins and promoting formation of/protecting the assembled SNARE 
complexes.  
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The lab’s previous conclusion that Sec6 decreased the rate of binary SNARE 
assembly was based on two independent lines of evidence – a quantitative decrease in the 
rate of depletion of one of the reactants, Sso1, and a qualitative observation of less 
SNARE complex formation on a native gel over time. These two lines of evidence 
supported each other; however, it was difficult to incorporate exocytic trafficking into the 
overall world-view of intracellular trafficking in general, and the field was forced to 
conclude that exocytic trafficking was an outlier. Therefore, I sought to determine if 
inhibition of SNARE assembly was truly the function of the Sec6:Sec9 interaction. 
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Major Conclusions 
Our biochemical studies identified, for the first time, an interaction between a 
subunit of the yeast exocyst tethering complex and assembled exocytic SNARE 
complexes (Figure 2.10). This Sec6:SNARE complex interaction is important for 
function in vivo, as mutations in Sec9 that disrupt the Sec6:SNARE interaction lead to 
synthetic growth defects in combination with mutations in exocyst subunits and in the 
SM protein Sec1 (Figure 2.6).   
Due to the disordered and flexible nature of Sec9, identification of residues 
central to the Sec6:Sec9 interaction required use of the zero-length cross-linker EDC and 
tandem mass spectrometry analyses. We expanded existing protocols for these 
experiments to include a time course (Chang et al., 2004); this allowed us to visualize 
which cross-links formed and how the amount of each cross-link changed over time. 
These experiments also allowed us to better understand how an IDP interacts with a well-
folded partner in the presence of a cross-linker, and highlight the “fuzziness” that is 
inherent to ordered-disordered protein interactions (Tompa and Fuxreiter, 2008). Our 
cross-linking analyses identified a stretch of residues in the inter-helical region of Sec9 
that are likely involved in the interaction with Sec6 (Figure 2.5), and we mutated this 
five amino acid stretch to a charged patch to generate the sec9-142 allele (Lys-533 to 
Glu, Leu-534 to Glu, Met-535 to Glu, Arg-536 to Glu, and Glu-537 to Arg). Our 
phenotypic analyses suggested that exocytic trafficking is impaired in the sec9-142 yeast 
strain (Figure 2.6); however, these mutations were not sufficient to disrupt the Sec6:Sec9 
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direct interaction at our level of detection (Figure 2.7). We decided that a functional test 
in vitro would be a better way to determine the basis of the in vivo growth defect. 
Our in vitro quantitative biochemical analyses of the sec9-142 protein and its 
ability to form SNARE complexes in the presence of the exocyst subunit Sec6 revealed 
unexpected results that contradicted published findings (Sivaram et al., 2005). We tested 
the purified wild-type and mutant Sec9 proteins in an optimized SNARE complex 
assembly assay (Nicholson et al., 1998; Sivaram et al., 2005) and found that Sec6 has no 
appreciable effect on the rate of SNARE complex assembly regardless of the Sec9 
protein variant used (Figure 2.8). One possibility was that exocyst plays a very different 
role in exocytosis than other MTCs perform at other stages of membrane trafficking; 
however, subsequent analyses instead suggest that the previous data were misinterpreted 
(Figure 2.9). We show here that Sec6 can bind both the binary Sec9:Sso1 and ternary 
Sec9:Sso1:Snc2 SNARE complexes and that these interactions are disrupted by the Sec9-
142 mutations (Figure 2.10). We therefore conclude that the synthetic growth defect 
observed in sec9-142 cells is due to a disruption of the Sec6:SNARE complex interaction 
rather than a loss of Sec6-mediated SNARE assembly inhibition.  
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Implications 
Tethers and SNAREs in trafficking 
Most MTCs, including exocyst, interact with their cognate SNARE complexes or 
with individual SNARE proteins (Arasaki et al., 2013; Balderhaar et al., 2013; Collins et 
al., 2005; Conibear et al., 2003; Diefenbacher et al., 2011; Krämer and Ungermann, 2011; 
Lobingier and Merz, 2012; Lürick et al., 2015; Pérez-Victoria and Bonifacino, 2009; 
Shestakova et al., 2007; Sivaram et al., 2005). However, the function of these interactions 
is not well understood. The best studied of the MTC-SNARE complex interactions is 
between HOPS and its cognate SNARE proteins/SNARE complex, which appears to 
serve several functions. First, HOPS recruitment to the assembled SNARE complex is 
important for maintaining its localization at sites of vacuole fusion (Wang et al., 2003). 
Secondly, HOPS competes with the disassembly machinery (Sec17/Sec18) for binding to 
the assembled SNARE complex and preferentially binds to trans-SNARE complexes; this 
likely protects the pre-fusion trans-SNARE complex from disassembly (Collins and 
Wickner, 2007; Collins et al., 2005). One of the HOPS subunits can bind both the v-
SNARE and t-SNARE and these interactions may align the proteins for proper complex 
formation (Baker et al., 2015). Finally, HOPS has a higher affinity for properly-formed 
SNARE complexes than for non-cognate SNARE complexes, suggesting that it may 
“proofread” the SNARE complex prior to fusion (Starai et al., 2008). Other 
MTC:SNARE interactions appear to have similar functions, but have not yet been studied 
in as much mechanistic detail.  
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It is interesting to speculate that exocyst-SNARE complex interactions may have 
similar roles to the HOPS-SNARE interactions. In support of this hypothesis, a cluster of 
point mutations in Snc2 (Snc2-M2) that face outward from the assembled SNARE 
complex, and are therefore exposed when the complex is fully assembled, disrupt a direct 
interaction between Sec6 and Snc2 resulting in a mild exocyst polarization defect (Shen 
et al., 2013). Our studies show that Sec6 has a higher affinity for the Sec9:Sso1:Snc2 
ternary complex than the Sec9:Sso1 binary complex (Figure 2.10), suggesting that Snc2 
may be providing additional binding residues on the surface of the assembled SNARE 
complex for Sec6 binding. The Snc2-M2 mutant protein may also disrupt Sec6:SNARE 
complex binding, similar to the disruption seen with the Sec9-142 mutant, and thus the 
Sec6:SNARE complex interaction may help maintain proper polarization of the exocyst 
complex. 
The fact that Sec6 appears to have a higher affinity for the fully assembled 
SNARE complex also suggests that Sec6 may serve a protective role, similar to HOPS, 
and compete with the Sec17/18 disassembly machinery for binding to the complex. This 
hypothesis would predict that Sec6 may have an even higher affinity for the complex 
when it is in the trans conformation, rather than the cis-like conformation lacking trans-
membrane domains tested here. Additionally, Sec6 and the exocyst may cooperate with 
Sec1 for this function, as the SM proteins have been shown to compete with the Sec17 
for binding to assembled SNARE complexes in other stages of trafficking (Lobingier et 
al., 2014). 
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The studies presented here provide a crucial step towards deciphering the role of 
exocyst-SNARE interactions in exocytic growth in yeast and suggest future experiments 
to test the conservation of this interaction in other model systems. Additionally, as I have 
only identified a novel interaction here, many critical mechanistic questions remain 
unanswered. Many other MTC:SNARE interactions take place in the context of the 
assembled MTC; is the entire exocyst complex involved in the SNARE interaction or just 
the Sec6 subunit? Mutations in Sec6 cause mislocalization of the entire exocyst complex 
(Songer and Munson, 2009); is the assembled SNARE complex, through interactions 
with Sec6, required to polarize the exocyst at sites of fusion? HOPS can also act with its 
SM protein Vps33 to protect properly formed complexes from the disassembly 
machinery prior to vesicle fusion, and other SM proteins have been shown to serve a 
similar role (Lobingier et al., 2014); are Sec6 or the exocyst complex protecting the 
assembled SNARE complex prior to vesicle fusion, possibly through the SM protein 
Sec1? These questions will be discussed in more detail in the Future Directions section, 
below. 
 
IDP:ordered protein interactions 
During the cross-linking experiments used to identify the critical Sec6:Sec9 
binding site residues, we were presented with a larger dataset than expected due to the 
presence of the IDP Sec9. This required developing hypotheses and methodologies to 
understand how a disordered protein would interact with an ordered protein during a 
cross-linking reaction. Unlike other studies using EDC to map binding sites (Chang et al., 
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2004), the presence of an IDP in our reaction necessitated the use of a cross-linking time 
course. If we had examined just the cross-links identified at the end of the reaction, we 
would have been left with an overwhelming dataset that was impossible to interpret 
(Figure 2.2). The large number of cross-links identified was likely due to the flexible 
nature of Sec9; the protein can sample more conformations and activated cross-linkable 
residues have a higher probability of being proximal. However, by studying the behavior 
of the cross-linked peptides over time we were able to separate different classes of cross-
links and filter the dataset.  
The behavior of the secondary crosslinks is also unique to the ordered:disordered 
protein interaction. In an ordered:ordered system, the cross-links that form later in the 
reaction are more likely to cause structural changes to one or both binding partners; this 
may cause them to be less reliable indicators of the binding site. However, because Sec9 
remained flexible, a higher fraction of the secondary crosslinks can capture the native 
state of Sec6. This resulted in more cross-links to examine, but also allowed us to identify 
individual binding residues rather than binding domain regions.  There is, however, the 
possibility that some of the cross-links destabilized Sec6, but if so, we have no way of 
identifying which ones in order to exclude them from our analysis.  
Finally, the patch we identified and mutated on Sec9 was not sufficient to disrupt 
Sec6:Sec9 direct binding. This is a hallmark of ordered:disordered interactions, as many 
predict that IDPs utilize multiple low affinity binding sites to bind their ordered partner 
(Uversky, 2002; 2013; Wright and Dyson, 2015). This is evolutionarily advantageous – 
IDPs are able to withstand random mutations without losing their necessary functions or 
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binding partners (Gitlin et al., 2014), but makes generating specific loss-of-binding 
mutants challenging. The C-terminal domain of Sec6 alone was not sufficient to bind to 
Sec9 despite Sec9 cross-linking to this domain; this suggests that the binding sites are 
scattered across both domains of Sec6 (Sivaram et al., 2005). However, the Sec9 
mutations were sufficient to disrupt Sec6 binding once Sec9 was folded into the SNARE 
complex. This makes sense, as the folded Sec9 will likely have lost the rest of its contacts 
on Sec6 with only the inter-helical residues remaining exposed. 
The loss of binding once the mutant protein is incorporated into the SNARE 
complex raises an interesting question – is the Sec6:Sec9 direct interaction truly 
necessary or functional in vivo? Similarly, is the Sec6:binary SNARE interaction 
necessary or functional in vivo? Or are these interactions a product of studying proteins in 
isolation, and not physiologically relevant? The flexible nature of Sec9 could result in 
non-physiological contacts with the free Sec6, and interaction with the binary SNARE 
complex could be a weaker version of the fully assembled SNARE interaction lacking the 
additional binding sites provided by Snc2. Similarly, is the Snc2:Sec6 direct binary 
interaction physiologically relevant in vivo, or a lower affinity version of the 
Sec6:SNARE interaction occurring due to the disordered nature of Snc2 outside the 
SNARE complex? Testing this will require additional mutations, likely scattered across 
the length of the proteins, that maintain the Sec6:SNARE complex binding but disrupt 
Sec6:Sec9 direct binding. 
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Interpreting the SNARE complex assembly assay 
One of the major conclusions of this study was that the presence of Sec6 does not 
change the rate of SNARE complex assembly, in contrast to previously published data 
(Sivaram et al., 2005). This conclusion was based on the foundation of two lines of 
evidence: quantitative curve fitting from a gel filtration mobility shift experiment, and a 
qualitative observation of less SNARE complexes forming by a native gel mobility shift. 
However, by looking at the whole picture of the gel filtration profiles, it became clear 
that a Superdex 200 column was unable to resolve the free Sec6 and free Sso1 peaks. To 
confound matters, the percent of overlap between the free Sec6 and free Sso1 peaks 
changed over time due to the changing binding interactions in solution. The gel filtration 
assay was sufficient when only two components were present (and one of the components 
has essentially no extinction coefficient at the concentrations used), but once more 
components were added the data became difficult to interpret.  
However, was the gel filtration assay sufficient even in its original incarnation?  
Re-working the SNARE complex assembly assay, and re-analyzing the previous gel 
filtration data, illuminated many unknown factors about the interplay between the various 
proteins. The equation derived and used in the original study was meant for a simple 
second order reaction – the SNARE domains of 
Sec9 and Sso1 react to form the assembled binary 
complex with rate k1 (Figure 3.1). However, 
when the full-length Sso1 is used, the equation is 
Figure 3.1 - Simple second order reaction of 
SNARE assembly. Simple second order reaction 
where the two SNARE proteins form the binary 
SNARE complex. 
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not longer sufficient – it does not take into 
account that Sso1 is autoinhibited and must 
interconvert between its closed, non-reactive 
form and its open, reactive form (Figure 3.2). 
This means that at any given time, the 
concentration of reactive Sso1 is much lower than the concentration of reactive Sec9. 
 This changes the way we mathematically fit the results of the experiment, because 
we can no longer assume an equal concentration of reactants. However, this is not quite a 
pseudo first order reaction because while the total concentration of Sso1 is decreasing at a 
predictable rate (k1) we do not know how the concentration of Sso1O is changing over 
time (controlled by k2/k-2). Therefore, we do not understand how the two components 
contribute to the rate of the reaction, and are likely measuring k2 rather than k1. 
 Addition of Sec6 into this reaction 
changes several additional factors. Because Sec6 
can interact with Sec9, it reduces the 
concentration of available Sec9 at any given time. 
If the reaction is depended on the concentration 
of Sec9, instead of the concentration of open 
Sso1, this may alter the rate of the reaction. If 
Sso1 is unable to fully compete with Sec6 for 
Sec9 binding, this may alter the extent of the 
reaction (what percentage of Sso1 will be in 
Figure 3.2 - Sso1 interconverts between an 
open and closed conformation, with the closed 
conformation being more prevalent; this changes 
the amount of open Sso1 available to react with 
Sec9 at any given time. 
Figure 3.3 – Addition of Sec6 changes the 
amount of available Sec9. Addition of Sec6 to 
the reaction changes the amount of available 
Sec9 at any given time. This can change the rate 
of the reaction (if the rate is dependent on the 
concentration of Sec9, and if the change in 
concentration is enough to affect the rate), the 
extent of the reaction (how much of each reactant 
is in the SNARE complex at t=∞), or both. 
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SNARE complexes at t = ∞) (Figure 3.3). As observed in Figure 2.8, the addition of 
Sec6 results in ~30% of Sso1 remaining un-complexed at t = ∞, suggesting that the final 
equilibrium state of all proteins in the reaction involves a portion of Sec9 sequestered by 
Sec6. Additionally, because Sec6 can interact with the Sec9:Sso1 SNARE complex (as 
shown here), this may change the amount of free Sec6 over time that can interact with 
Sec9 (Figure 3.4).  
 The changes in SNARE complex assembly with the Sec9-142 protein provide 
some insight into the interplay between the various proteins. In our analysis, the addition 
of Sec6 causes a reduced extent of SNARE assembly with Sec9, and it appears to have no 
effect in combination with Sec9-142. This suggests that something about Sec9-142 
changes the final equilibrium between all components of the reaction. Because we know 
that the Sec6:Sec9-142 interaction still occurs, there are two potential explanations for 
this phenomenon. One possibility is that the direct binding reaction is altered, without 
substantially changing k3 or k-3,, resulting in Sso1 being able to compete Sec9-142 away 
from Sec6. Another is that the Sec6:Sec9-142 interaction does not interfere with SNARE 
complex formation, due to changes in which 
residues of Sec9-142 make contact on Sec6, and 
that SNARE complex assembly releases Sec6. 
Therefore, the changes observed when using the 
Sec9-142 protein suggest that Sso1 cannot 
compete with Sec6 for Sec9 while the binding site 
residues in the inter-helical region are present.  
Figure 3.4 – Sec6 can interact with the binary 
SNARE complex. Sec6 can also interact with the 
binary SNARE complex, changing the amount of 
Sec6 available at any given time.  
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In order to fully understand this assay, several pieces of additional information are 
needed. First, what is the concentration of active Sso1 at the beginning of the reaction? 
Dropping the concentration of Sec9, and observing any changes in k1, will begin to 
answer this question as k1 will depend more on the Sec9 concentration once Sec9 is the 
limiting reagent. However, because the active Sso1 can be replenished by the 
autoinhibited Sso1, this will require re-working the equations. Secondly, using an assay 
that allows direct measurement of the formed complex will be a better way to determine 
k1 – this has previously been done using circular dichroism, as formation of the SNARE 
complex results in a large increase in helicity, but the high helical content of Sec6 may 
result in too much background signal that will swamp the helical change by SNARE 
complex formation.  Despite these problems, this assay is still useful, as any reagent that 
increases the amount of open Sso1, and therefore increases k2, will result in an increase in 
k1. Therefore, this assay can be used to screen for proteins that promote “opening” of 
Sso1 once candidates have been identified.  
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Short-Term Additional Studies 
One of the large remaining questions from these studies is whether the 
Sec6:SNARE interaction is stand-alone or if it occurs in the context of the entire exocyst 
complex. Other 
MTC:SNARE interactions 
involve either the intact 
complex or multiple subunits 
interacting with the SNARE 
proteins. Until recently, this 
was a difficult question to 
solve. Previous attempts 
showed that a subset of 
exocyst subunits were unable 
to interact with Sec9, and 
whole cell lysate 
fractionation showed Sec9 
outside the pool of 
assembled exocyst (Figure 
3.5, (Morgera et al., 2012)). 
However, this experiment was detecting interactions with Sec9 without incubating the 
yeast with sodium azide/sodium fluoride to prevent disassembly of the SNARE 
complexes during cell lysis (Grote and Novick, 1999). Now that we know to look for an 
Figure 3.5 – Sec9 primarily co-fractionates with non-exocyst fractions. 
Sec9 primarily co-fractionates with non-exocyst fractions, suggesting that it 
does not interact with the assembled exocyst complex. Originally published 
in Morgera et al., 2012 and re-produced here with permission. 
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interaction with the SNARE complex, these experiments can be repeated. Additionally, 
recent successes at purifying the intact exocyst complex (Heider et al., 2016) provide a 
tool to test for SNARE binding to the entire complex. These experiment are limited for 
now, however, by the fact that neither the exocyst nor the SNARE complex can be 
concentrated high enough for quantitative binding studies. 
Another unknown in these experiments is the role of Sec1. The SM protein also 
binds assembled SNARE complexes, and the linker region has been shown to be required 
for this interaction (Togneri et al., 2006). Therefore, the Sec9-142 mutation in the linker 
region may also be disrupting the Sec1:SNARE complex interaction. Similar to the 
exocyst, it is difficult to concentrate Sec1 high enough for these quantitative binding 
studies; however this barrier may be overcome easier than concentrating the exocyst, and 
therefore present an ideal first step in further characterization of the Sec9-142 mutation. 
A large panel of Sec1 mutations that disrupt SNARE binding are also available and 
would be ideal for testing for synthetic interactions with the sec9-142 strain in vivo 
(Hashizume et al., 2009).  
As previously mentioned, the Snc2-M2 mutant that disrupts Sec6 binding may 
also disrupt Sec6:SNARE binding (Shen et al., 2013). This idea can be tested by 
purification of SNARE complexes containing either the Snc2-M2 mutation alone or both 
the Sec9-142 and Snc2-M2 mutant proteins in the same complex. Similarly, generation of 
a sec9-142/snc2-M2 strain will allow testing of synthetic effects of the double mutation. 
Initial attempts at generating this strain have already begun, but the snc2-M2 strain has 
defects in sporulation that complicate strain generation. Therefore, genomic replacement 
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of SEC9 with the sec9-142 allele in the snc2-M2 strain is likely the best method for 
generating this double mutant moving forward. 
Finally, the snc2-M2 allele results in a mild mislocalization defect of the exocyst 
complex. If this defect is due to a loss of Sec6:SNARE binding, then the sec9-142 strain 
may show a similar mislocalization defect. Therefore, localization studies of the exocyst, 
Sec1, and Sso1 in the context of the sec9-142 allele may provide more clues as to the 
function of the Sec6:SNARE interaction in vivo.  
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Long-Term Future Directions 
Are SNARE complexes the exocyst anchor? 
 One of the functions of the HOPS:SNARE interaction is to maintain localization 
of the HOPS complex at sites of vacuole/lysosomal fusion (Wang et al., 2003). HOPS 
and the SNAREs then recruit each other to achieve the concentrations necessary to 
mediate fusion. Previous work in the lab identified two highly conserved patches on the 
surface of Sec6 and mutation of these patches resulted in mis-localization of the intact 
exocyst complex (Songer and Munson, 2009). These alleles resulted in severe growth and 
secretion defects in vivo that can be rescued by overexpression of individual SNARE 
proteins. It was hypothesized in that study that the defect was due to loss of binding to a 
putative “anchor” protein, and that the SNARE overexpression allowed bypass of the 
tethering function of the exocyst. However, were those mutations in Sec6 disrupting 
SNARE binding? And 
was a loss of SNARE 
binding the cause of the 
exocyst mislocalization? 
These mutations were not 
sufficient to disrupt 
Sec6:Sec9 direct binding, 
similar to the work 
presented here; however, 
in support of this  
Figure 3.6 – Sec9-142 residues cross-link adjacent to Sec6-54 and Sec9-49. 
The sites previously identified on Sec6 that disrupt exocyst localization, Sec6-54 
(green) and Sec6-49 (blue) are proximal to the sites where Sec9-142 residues 
crosslink on Sec6 (red). This suggests that the defect observed in the Sec6 
mutants, of exocyst mislocalization, may be related to the loss of SNARE binding 
observed. 
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hypothesis, the Sec9-142 residues cross-link to regions adjacent to the these 
mislocalization patch mutants on Sec6, suggesting that they may be adjacent to potential 
SNARE binding sites (Figure 3.6).  
 Some work has already begun to resolve this – specifically, the Sec6 mutants 
were tested for Snc2 binding defects, and were not sufficient to disrupt binding (Margaret 
Heider, unpublished data). However, as seen with the Sec9 mutant, it may be that these 
mutations are not sufficient to disrupt binding to the disordered protein while sufficient to 
disrupt binding to the assembled SNAREs. And, while the Snc2-M2 mutation was 
sufficient to disrupt binding to Sec6, this mutation consisted of multiple residues across 
the N-terminal half of the SNARE motif. This may have provided enough mutations to 
disrupt several low-affinity sites the IDP Snc2 uses to bind Sec6.   
There are several additional studies that are necessary to resolve this question. 
Firstly, does SNARE overexpression rescue the mislocalization defect of these Sec6 
mutants? If overexpression of the SNAREs is truly allowing for bypass of the exocyst’s 
tethering function, then strains overexpressing SNARE proteins should still have an 
exocyst mislocalization defect. Similarly, are the Sec6 mutant proteins sufficient to 
disrupt binding of Sec6 to the assembled SNARE complex? These proteins are well 
folded in vitro, and therefore would be excellent candidates for future SNARE complex 
binding studies. Finally, studying the localization of the exocyst in the sec9-142 strain 
will begin to resolve if the exocyst:SNARE interaction is required for proper exocyst 
localization. 
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Do Sec6 or the exocyst protect pre-fusion SNARE complexes from disassembly? 
The idea of SNARE binding being a determinant for exocyst polarization is 
intriguing, but may only be one function of the interaction. While bound, the exocyst may 
also serve a stabilizing/protective function, similar to HOPS, and compete with the 
Sec17/Sec18 disassembly machinery for SNARE binding to prevent disassembly of 
properly formed SNARE complexes prior to vesicle fusion.  
Studies have already shown this role for a subset of the the SM proteins. Sly1, the 
SM protein involved in ER and Golgi fusion events, and the HOPS SM subunit Vps33 
can both protect assembled SNARE complexes from disassembly by Sec18 (Lobingier et 
al., 2014). Does the exocytic Sec1 have a similar function? And does it cooperate with 
Sec6 or the exocyst to accomplish that role? It is possible to test this using a SNARE 
disassembly assay previously described, modified to include the exocytic SNARE 
complex and the SM protein Sec1, Sec6, or both (Lobingier et al., 2014). Additionally, 
synthetic tests with overexpression of Sec17 and/or Sec18 in combination with either 
Sec1 mutants defective for SNARE binding (Hashizume et al., 2009), or the Sec9-142 
SNARE complexes described here defective for Sec6 binding, will begin to unravel any 
requirement for SNARE binding when cells more promiscuously disassemble SNARE 
complexes. 
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Liposome fusion assays 
Many studies used to understand SNARE mediated vesicle fusion, at least after binary 
SNARE complex assembly, have relied upon liposome fusion assays (McNew et al., 
2000; Nickel et al., 1999; van den Bogaart et al., 2010). In these assays, liposomes are 
reconstituted with the SNARE proteins required for the specific fusion event, and the rate 
of fusion is measured by lipid mixing, content mixing, or a combination of both (Diao et 
al., 2012; 2013; Kyoung et al., 2013; Xu et al., 2011). While many of these assays have 
shown a dependence on lipid compositions, and the findings are therefore not necessarily 
physiologically relevant if using non-native lipid compositions (Tong et al., 2009; 
Vicogne et al., 2006; Zick et al., 2014), they are an excellent way to determine how 
addition or loss of various factors can change the rate of fusion. By using whole cell 
lysate depleted of components or by adding in vitro purified regulatory proteins, it is 
possible to generate a picture of how each component contributes to the overall 
regulatory process. Since these assays require low concentrations of reactants, it is also 
possible to test the contribution of components that are difficult to concentrate – 
specifically the exocyst and Sec1. Therefore, these assays may be an ideal next step in 
de-convoluting the contribution of each protein family in overall regulation of SNARE 
assembly and vesicle fusion. 
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Final Thoughts 
The studies presented here are a first step in understanding whether the exocyst, a 
multi subunit tethering complex, behaves similarly to the tethering complexes in other 
trafficking steps. While the common set of interactions has been known for some time, 
the idea that an exocyst subunit reduced the rate of SNARE complex assembly set the 
exocyst apart. Now, having identified that the SNARE interaction is not inhibitory to 
SNARE complex formation, it is possible to design experiments that will begin to dissect 
the specific functions of this interaction. 
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APPENDICES 
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Appendix A: Table of all identified Sec6-Sec9 cross-links 
The cross-linking experiments (Figures 2.2-2.5) included eight different 
experimental setups, and one re-analysis of a previous dataset. Each of these experiments 
produced an overlapping list of cross-linked peptides, which are detailed in Table 3.1. 
The peptides identified are listed for each protein, and the residue number of the cross-
linked amino acid is denoted (where identifiable) in red. In cases where two adjacent 
residues are chemically capable of cross-linking, both are colored red; the peptide was 
then duplicated in the sheet with each possible cross-linked residue represented. 
The experiments are as follows: 
Experiment 1: 7.5 µM Sec6/Sec9, cross-linked with EDC and Sulfo NHS for 0-120 min 
Experiment 2: A refinement of the data set from experiment 1. 
Experiment 3: 7.5 µM Sec6/Sec9, cross-linked with EDC alone for 0-120 min  
Experiment 4: 7.5 µM Sec6/Sec9, cross-linked with EDC and NHS for 0-120 min  
Experiment 5: 7.5 µM Sec6/Sec9, cross-linked with EDC and Sulfo NHS for 0-120 min 
Experiment 6: 1 µM Sec6/Sec9, cross-linked with EDC alone for 0-120 min 
Experiment 7: 7.5 µM Sec6/Sec9, cross-linked with EDC alone for 0-5 min 
Experiment 8: 1 µM Sec6/Sec9, cross-linked with EDC alone for 60 min 
Experiment 9: 7.5 µM Sec6/Sec9, cross-linked with EDC alone for 0-5 min 
The table is sorted according to the reproducibility of each cross-link in varying 
experiments. Each identified cross-link in each experiment is color coded to represent the 
class it belongs to, and each residue number is color coded according to which class(es) 
of cross-links it participates in (yellow, early-forming; blue, late-forming; green, both 
early-forming and late-forming) (Figure 2.4 and Figure 2.5).   
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Table 1 - Page 1 
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Table 1 – Page 2 
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Table 1 – Page 3   
Table 4.1 – All cross-links identified during cross-linking and mass spectrometry analyses. The 
peptides identified are listed, with the cross-linked amino acid in red; the corresponding residue number 
is in the next column. Each cross-link identified in each experiment is color-coded to represent the class it 
belongs to, and each residue is color coded to represent the classes of cross-links it participates in. The 
data is sorted so the most reproducible cross-links are listed first.  
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Appendix B: Sec6-Sec6 cross-links identified in Sec6-Sec9 cross-linking 
dataset 
The data from cross-linking experiment 1 (see Appendix A and Table 4.1) were 
analyzed for any Sec6-Sec6 cross-links that formed during the Sec6-Sec9 cross-linking 
reaction. Previous work showed that Sec6 dimerizes in vitro, and that the Sec6:Sec9 
interaction is between two copies of each protein (Sivaram et al., 2005). The cross-links 
identified are shown in Table 4.2, and summarized in Figure 4.1. However, it is not 
possible to distinguish between intra- and inter-molecular cross-links without labeling 
one of the two protein copies. 
Figure 4.1A shows all cross-linked residues labeled according to the class of 
cross-link as defined in Appendix A and Figure 2.4. Unlike the Sec6:Sec9 interaction, 
there is no IDP present in these cross-links; accordingly, each cross-link identified in the 
C-terminal domain generally contains at least one residue in a flexible loop region of the 
crystal structure, likely because the flexibility allows the cross-linker activated residues to 
come into contact. Many of the cross-links in the N-terminal domain also occur in or near 
regions of predicted flexibility (Figure 4.1B, with the residues removed for better 
visualization of the predicted helical secondary structure). There are also residues that 
cross-link to both Sec6 and Sec9, denoted with asterisks above the N-terminal domain 
structure, suggesting that these residues are exposed and easily cross-linked during the 
cross-linking reaction. 
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Surprisingly, only one cross-link occurred between the C-terminal and N-terminal 
domains. Similarly, there are fewer cross-links in the C-terminal domain than in the N-
terminal domain in general. However, because this cross-linking was run in the presence 
of Sec9, it is not possible to determine if these cross-links are capturing the native state of 
the Sec6:Sec6 interaction, or even the native conformation of the protein itself. 
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Table 4.2 - All Sec6-Sec6 cross-links identified during cross-linking 
and mass spectrometry analyses. The peptides identified are listed, 
with the cross-linked amino acid in red; the corresponding residue 
number is in the next column. Each cross-link identified is color-coded 
to represent the class it belongs to, and each residue is color coded to 
represent the classes of cross-links it participates in. The data is sorted 
in residue number order, with the most N-terminal residue in the cross-
link in the left-hand column. 
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Figure 4.1  - Sec6-Sec6 cross-links identified in the Sec6-Sec9 cross-linking reaction. The cross-links are mapped 
onto the C-terminal domain structure (Sivaram et al., 2006) and a linear segment representing the N-terminal domain. 
The boxes on the N-terminal domain represented putative helices by secondary structure prediction (SOPM algorithm), 
and the asterisks denote residues that cross-link to both Sec6 and Sec9. A) Each residue is colored, as in Figure 2.4, 
according to the class of cross-link it participates in. Each cross-link contains at least one residue in/near a flexible loop 
region of the protein, suggesting that the protein flexibility greatly contributes to its availability to crosslink. B) The 
residues are removed from the N-terminal region to allow better visualization of the secondary structure prediction.  
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Appendix C: Plasmid-based analysis of Sec6/Sec9 point mutations in vivo 
The first attempt to identify the residues necessary for the Sec6:Sec9 interaction 
was via in vivo mutagenesis. CEN LEU2 plasmids bearing a single point mutation in 
either SEC6 or SEC9, both as an alanine substitution and a charge reversal, were 
introduced into yeast where the genomic copy was deleted; the deletion was covered by a 
wild-type plasmid with the URA3 auxotrophic gene. The mutant-containing plasmids 
were transformed into the yeast, and the wild-type gene was selected against using 5-
fluoroorotic acid (5-FOA). Two distinct colony sizes were identified for all mutations, 
and one colony of each size was selected; each of these individual mutant strains were 
then assayed for growth defects at varying temperatures on both rich YPD media and 
minimal synthetic media (Figure 4.2). 
While the strain containing the E537R mutation had a growth defect at high 
temperatures, there was concern about the colony size as small colonies can be indicative 
of other defects, and may confound the analysis (Dr. Reid Gilmore, personal 
communications). Therefore, the strain was re-constructed by integrating the mutation 
into the genome. Upon analysis of the newly generated strain, a growth defect was no 
longer evident (Figure 4.3). This led to questions regarding the copy number of the yeast 
CEN plasmids, and if that would compensate for any mild binding defects. Moving 
forward, all mutations were integrated into the genome (Figure 2.6). However, the Sec9 
Glu-537 to Arg mutation was carried forward for in vitro studies (Appendix D), and 
eventually became the final mutated residue in the sec9-142 allele. 
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Appendix D: Alternative methods of quantifying Sec6:Sec9 direct binding 
Using gel filtration to detect in vitro binding defects 
The Sec6:Sec9 interaction was originally studied by size exclusion 
chromatography; equimolar Sec6 and Sec9 were incubated together for 1 hr at 4 C, and 
then run over a Superdex 200 gel filtration column. The purified Sec6 runs as a dimer, 
eluting with a retention volume of approximately 13.5 mL; when it binds Sec9, it elutes 
with a retention volume of approximately 12 mL, indicating that the complex now has a 
larger hydrodynamic radius. Therefore, we hypothesized that changes in the binding 
affinity would result in a return of Sec6 to its uncomplexed position. 
Multiple protein constructs, with mutations in both Sec6 and Sec9, were tested by 
this assay. Initial experiments showed a mild binding defect with Sec9 (Glu-537 to Arg), 
Sec9 (Leu-534 to Glu), Sec9-142, and Sec6 (Lys-515 to Asp) (Figure 4.4). However, 
upon examination of the concentrations of the various constructs, it became clear that the 
concentration of Sec9 was over-estimated (due to contaminants in the prep) while the 
concentration of Sec6 was under-estimated (likely due to incomplete hydrolysis during 
the ninhydrin assay) (Figure 4.5B). When the concentration of Sec9-142 (the most severe 
disruption of binding mutant by gel filtration) was re-calculated and the assay re-run, the 
binding defect was lost (Figure 4.5A). Therefore, we concluded that gel filtration was 
likely not sensitive enough to detect changes in binding affinity.  
However, the fact that a binding defect was detected when the proteins were not 
incubated at equimolar concentrations, despite the wild type proteins showing complete 
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binding even with the concentration differences, suggests that the mutants that showed 
weakened binding may still have a mild binding defect. Sec9-142, though, did not show a 
binding defect by direct binding assays; a full binding curve, and calculation of the Kd for 
each interaction, may show very mild differences that the six concentration experiment 
could not detect (Figure 2.7).  
 
Using Fluorescence Polarization to determine the Kd of the Sec6:Sec9 interaction 
Another potential way of measuring the Kd of the Sec6:Sec9 interaction was 
using fluorescence polarization. Sec6 is a large protein (~90 kDa) that dimerizes in 
solution; Sec9 is a much smaller protein (~25 kDa) that is a disordered monomer in 
Figure 4.4 – Equimolar gel filtration studies of Sec6 and Sec9 mutant constructs. 10 µM each protein were used to 
test various Sec6 and Sec9 mutant constructs for binding defects. These studies suggested that Sec9 (Glu-537 to Arg), 
Sec9 (Leu-534 to Glu), and Sec9-142 showed binding defects, with Sec9-142 being the most severe. A mild defect was 
also seen with Sec6 (Lys-515 to Asp), which is one of the residues that is a cross-linking partner for Sec9 (Glu-537). 
Grey lines indicate the position of uncomplexed Sec6 dimer (right-most) and the Sec6:Sec9 complex (left-most). 
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solution. Therefore, the Sec6:Sec9 interaction (which involves two copies of each 
protein) will be significantly larger and affect the protein’s ability to tumble in solution.  
 I designed and produced a Sec9 construct with a C-terminal cysteine. Early 
attempts at purification showed little to no Sec9 after induction; this was fixed by altering 
the induction method (see modified Sec9 purification protocol in Chapter V). Once the 
purification was optimized, this construct was soluble, purified similarly to the wild-type 
Sec9, and was able to be concentrated. I used TCEP instead of DTT as a reducing agent 
to keep the free cysteine from forming disulfide bonds, as DTT needs to be removed prior 
to conjugation with a maleimide dye; however, upon addition of the TCEP, a large 
Figure 4.5 – The loss of binding observed in previous gel filtration experiments was due to a mis-calculation of 
the protein concentrations in the assay. A) A gel filtration profile showing Sec9-142 at 10 µM using the 
concentration measured by ninhydrin (bottom, grey), and a re-measurement of the same proteins when the 
concentrations were re-done using Krypton staining and a BSA standard. B) Gels showing 0.5 and 0.25 µg of protein 
according to the ninhydrin calculations with BSA as a loading control.   
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portion of the protein precipitated and was unable to be re-solubilized. 
Concentration testing suggested very little protein remained in 
solution. 
Despite the low concentration, I attempted to conjugate an 
Alexa488 Maleimide dye as described previously (Furgason et al., 
2009). After running on a Superdex 200 column, the eluted peak 
contained a very small amount of labeled Sec9 (Figure 4.6). Upon 
concentration, the Sec9 remaining precipitated. This avenue was 
abandoned due to the instability of the C-terminally tagged construct.  
While other attempts may have improved the solubility of the 
construct (adjusting the buffer conditions, different fluorescent dyes, using DTT instead 
of TCEP followed by buffer exchange), the propensity of the construct to aggregate was 
concerning as any aggregation might confound the anisotropy results.  
  
Figure 4.6 – 
Labeling of the Sec9 
C-terminal cysteine 
construct with 
Alexa488-
maleimide. 
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Appendix E: Sso1-Cysteine Constructs for Maleimide Labeling in SNARE 
Complex Assembly Native Gels 
The contaminant band from the Sec9 prep confounded the quantification of 
SNARE assembly by native gel because its migration resulted in partial overlap with the 
free Sso1 band. Therefore, I attempted to conjugate an Alexa488-maleimide to Sso1, and 
monitor the fluorescent Sso1 signal in an electrophoretic mobility shift assay (EMSA) as 
previously described (Furgason et al., 2009). This would allow me to measure the 
fraction of each time point bound, rather than the fraction of input lost.  
I therefore designed constructs with a cysteine at either the N-terminal or C-
terminal end of Sso1; the construct lacking the transmembrane domain does not contain 
any other cysteines. I then purified each construct as previously described (Munson et al., 
2000). The constructs purified and concentrated with no issues. They were then labeled 
and concentrated after labeling with still no complications.  
Each of the Sso1 constructs was incubated with Sec6, Sec9, or both, for 0-96 
hours. The resulting mixtures were then run on a pH 7.4 slab native gel as previously 
described (Furgason et al., 2009), and the fluorescently labeled protein was detected by a 
Typhoon fluorescence stage with the appropriate Alexa-488 filter set (Figure 4.7).  
Upon visualization of the native gel’s fluorescence, it became clear that there 
were problems with the fluorescent Sso1 constructs. The N-terminal Alexa construct 
showed decent resolution of assembled SNARE complexes; however, two bands are 
present for uncomplexed Sso1, and while the lower band is at least generally decreasing 
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over time in the conditions containing Sec9, we are unable to account for the upper band 
in the free Sso1 region. Finally, as the upper band appears to be increasing in intensity 
over time, we cannot quantify the total fluorescence in each lane. We therefore concluded 
that the N-terminal labeled construct is not feasible for these studies. 
Different and far more difficult problems accompanied use of the C-terminal 
fluorescent construct. In these experiments, a partially unresolved band likely due to 
cleaved or free dye is present at the bottom of each lane. Those lanes that do not contain 
the free dye did not behave in any predictable manner. We therefore also abandoned use 
Figure 4.7 – SNARE complex assembly by native gel, as visualized by fluorescent Sso1. N- and C-terminal cysteine 
constructs were generated and conjugated to Alexa488-maleimide. The fluorescent constructs were then incubated with 
Sec9 and/or Sec6 over 96 hours, and each time point was resolved on a native gel prior to visualization on a typhoon 
fluorescent stage. These reactions are impossible to quantify due to a number of reasons – un-expected bands, lack of 
expected bands, and potential cleavage of the fluorescent dye.  
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of the C-terminal labeled construct for these experiments, and turned instead to 
coomassie labeling of the native gels (Figure 2.8).   
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Appendix F: Modeling of the P.patens Type-V Myosin Cargo Binding Domain 
Over the last few years, we have developed a collaboration with Dr. Luis Vidali’s 
lab at WPI. The Vidali lab studies exocytic trafficking in the model system 
Physcomitrella patens, a moss species that has genetic tractability similar to budding 
yeast; these similarities allow both homologous recombination and siRNA silencing in 
the same organism (Cove et al., 2009).  
The growth of root tip cells in moss is a form of polarized growth that utilizes the 
same machinery as polarized growth and secretion in budding yeast: specifically Rab 
GTPase families, type V myosin motors, and the exocyst complex. Previous work in the 
lab identified that the type V myosin motor MyoXI is responsible for transport of vesicles 
to sites of active growth; however, identification of the vesicle-associated Rab GTPase 
has been elusive (Vidali et al., 2010). Sequence homology studies have narrowed it down 
to the RabA family, but are unable to further resolve the specific family member. 
Using structural homology modeling against the yeast type V myosin Myo2, the 
Vidali lab generated a set of mutations designed to disrupt binding with the Rab 
(Pashkova et al., 2006). These constructs were then tested for their ability to compliment 
loss of the wild-type MyoXI in vivo, and three mutations were identified. These 
mutations were then selected for in vitro binding studies with candidate RabA proteins, 
which I worked to develop with two undergraduate students (J. Garbarino and S. Kaptur 
et al., unpublished data).  
 97 
However, during the early phases of the in vitro studies, a new structure of the 
human MyoVb was released; this protein has higher sequence homology to the MyoXI 
from P.patens, and the paper more thoroughly maps the Rab-interacting surface from 
several systems. I therefore utilized the Modelr software suite to generate a homology 
model of the P.patens MyoXI cargo binding domain based on the human MyoVb cargo 
binding domain structure (Figure 4.8).  
Based on the new model, it appears that only two of the mutations that were 
carried into in vitro studies are surface exposed; the third is likely a buried hydrophobic. 
This was confirmed by attempts to purify a Val-1418 to Arg His-tagged protein construct 
– the protein had low expression levels, and was insoluble after the initial nickel 
purification (J. Garbarino and S. Kaptur, unpublished data).  
 
  
Figure 4.8 – Structural homology modeling of MyoXI based on the structure of the human MyoVb cargo 
binding domain. The mutations previously identified as failing to compliment loss of the wild-type MyoXI in P.patens 
are highlighted in yellow; two of these mutations appear to be to surface residues, but the third (Val-1418) is likely an 
internal residue. This agrees with preliminary in vitro data; the Val-1418 to Arg mutation is not soluble 
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